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ABSTRACT 
I. PALLADIUM (0)-CATALYZED ASYMMETRIC REARRANGEMENT
OF ALLYL ENOL ETHER FOR THE SYNTHESIS OF α -ARYL
QUATERNARY CARBON CENTER. 
II. SYNTHESIS OF CHIRAL TRYPTOPHAN ANALOGS AND
STUDIES TOWARDS SYNTHESIS OF TRYPROSTATIN A AND B.
by 
Nazim Uddin 
The University of Wisconsin - Milwaukee, 2015 
Under the Supervision of Professor M. Mahmun Hossain 
The development of efficient catalytic enantioselective synthesis of all carbon 
quaternary centers is a significant challenge in chemical synthesis due to the 
difficulties of carbon-carbon bond formation at quaternary center.  Using phase 
transfer catalyst we attempted to create quaternary carbon center via direct C-
alkylation of hydroxyarylacrylates, instead we obtained O-alkylated acrylates. We 
succeeded in C-alkylation which involves an indirect method via the O-alkylation 
of 3-hydroxy aryl acrylates and a subsequent [3, 3] sigmatropic rearrangement 
(Claisen rearrangement). The O-alkylated products are obtained in yields ranging 
from 65-85%, and the corresponding Claisen rearrangement products in yields 
ranging from 55-90%. Typically Pd(II) catalysts are used for this type of 
transformation. But several attempts at accomplishing an asymmetric Claisen 
rearrangement using metal Lewis acid catalysis failed due to insufficient activation 
of the Claisen substrate. Herein, we report the creation of all carbon stereocenters 
iii 
starting from 3-hydroxyarylacrylates modified allyl enol ether rearrangement 
reaction. We believe this is the first example of allyl enol ether rearrangement 
employing Pd(0) catalysts. The rearrangement reaction analogs takes place in 
excellent yields ranging from 80-95% and enantioselectivity ranging from 50-90% 
ee.  
Asymmetric synthesis of indole alkaloids is a major area in organic synthesis. 
Synthesis of chiral Tryptophans and its unnatural analogs has immense 
importance as they are building blocks for many natural products. Herein we 
describe the enantiospecific synthesis of ring-A substituted tryptophan derivatives 
from commercially available gramines using chiral phase transfer conditions. This 
one-pot reaction avoids protecting/de-protecting the indolylic nitrogen of gramine 
by choosing a chemoselective quaternization reagent, 4-(trifluoromethoxy)benzyl 
bromide  to produce an electrophilic salt intermediate, which is subsequently 
alkylated in good yield and high %ee. In an application of chiral tryptophans we 
attempted to synthesize tryprostatins. Tryprostatins are potent cancer drug, 
tryptostatin A reverses the resistance of cancer cells against antitumor drugs by 
arresting cell cycle progression at the G2/M phase. We have been able to make 
tryprostatin B using our proposed synthesis scheme, where one of the key 
intermediate is C-2 alkylated chiral tryptophan. Several challenges in the synthesis 
protocol and optimization of the chiral phase transfer catalyzed reaction are 
described.  
iv 
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I. PALLADIUM (0)-CATALYZED ASYMMETRIC REARRANGEMENT
OF ALLYL ENOL ETHER FOR THE SYNTHESIS OF α -ARYL 
QUATERNARY CARBON CENTER. 
CHAPTER 1. CLAISEN REARRANGEMENT AS A ROUTE TO 
QUATERNARY STEREOCENTERS. 
 1.1.1. Introduction 
The [3,3] sigmatropic rearrangement of allyl enol ethers for the formation γ,δ-
enones  is known as the Claisen rearrangement.1 This reaction was discovered 
over 100 years ago 2 and it has proven to be a powerful tool in the arsenal of the 
organic chemist. The Claisen reaction is mechanistically analogous to the Cope 
rearrangement. The Claisen Rearrangement may be viewed as the oxa-variant of 
the Cope Rearrangement. Both the Claisen and Cope rearrangements are known 
procedures to create defined tertiary and quaternary carbon centers as well as 
carbon-heteroatom bonds. Between these two reaction types, the Claisen 
rearrangement is the most used [3,3]-sigmatropic rearrangement because of the 
facile synthesis of the allyl enol ether system. Due to the smooth and frequently 
irreversible product formation this reaction is widely applicable for the synthesis of 
numerous organic intermediates. The [3,3] sigmatropic rearrangement is 
characterized by a highly ordered transition state where the repulsive interactions 
are minimized (Scheme 1). The reaction proceeds preferably via a chair transition 
state.  
2 
R
O
R2
R3
R1
O
R2
R3
R1
R
R
R3
R1
R2
O
Scheme 1. Transition state for Claisen rearrangement. 
As a result of the highly ordered nature of the six membered transition state, 
predictions are possible on the stereochemical outcome of the reaction based on 
the stereochemistry at the double bond. In general, chiral, enantiomerically 
enriched starting materials give products of high optical purity. 
Over the years the usefulness of the Claisen rearrangement has been realized and 
the reaction has drawn the attention of several research groups, which has been 
reflected in the large numbers of papers published in the literature on this reaction.3 
Because the product is a carbonyl compound, the equilibrium is usually favorable 
for product formation. 
Most of the uncatalyzed Claisen Rearrangement reactions described to date 
require temperatures of > 100 °C. The observation that electron withdrawing 
groups at C-1 of the vinyl moiety exert a positive influence on the reaction rate and 
the yield has led to the development of the following variations: 
Ireland Claisen Rearrangement: This moderate variation of the Claisen 
rearrangement utilizes the allyl ester of a carboxylic acid instead of an allyl enol 
ether (Scheme 2). The ester is changed to its silyl-stabilized enolate, which 
rearranges at temperatures below 100 °C. The direct product of the 
3 
rearrangement, a carboxylic acid silyl ester, cannot be separated and is hydrolyzed 
during workup. The Ireland-Claisen Rearrangement thus presents ready access to 
chain-extended carboxylic acids.  
O
O
1. LDA, -78 oC
2. Me3SiCl
O
OSiMe3
O
OSiMe3
HO
O
Scheme 2. Ireland-Claisen rearrangement. 
The Eschenmoser–Claisen rearrangement : This reaction proceeds from an allylic 
alcohol to a γ,δ-unsaturated amide, and was developed by Albert Eschenmoser in 
1964 (Scheme 3). 
OH
OMe
NR2
OMe
-2 MeOH
O
NR2
R2N
O
Scheme 3. Eschenmoser–Claisen rearrangement. 
 Johnson–Claisen rearrangement:  is the reaction of an allylic alcohol with an 
orthoester containing a deprotonatable alpha carbon (e.g. triethyl orthoacetate) to 
give an γ,δ-unsaturated ester (Scheme 3). 
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Scheme 4. Johnson-Claisen rearrangement. 
1.1.2. Synthesis of allyl enol ethers 
In the literature there have been several efficient procedures developed to 
synthesize the required allyl enol ethers have been developed such as the enol 
ether Claisen, the Johnson orthoester Claisen, and the Ireland silyl ketene acetal 
Claisen. The reactants for the Claisen rearrangement can be made from allylic 
alcohols by mercuric ion-catalyzed exchange with ethyl vinyl ether.4 The allyl vinyl 
ether does not necessarily have to be isolated but is usually prepared under 
conditions which lead to its rearrangement. The simplest of all Claisen 
rearrangements, the conversion of allyl enol ether to 4-pentenal, exemplifies this 
process (Scheme 5). 
 
 
Scheme 5. In situ formation of allyl enol ether followed by Claisen rearrangement. 
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Acid catalyzed cleavage can also be used to prepare the vinyl ethers (Scheme 6): 
 
 
Scheme 6. Preparation of allyl enol ethers through acid catalyzed cleavage. 
 
Allyl enol ethers can also be generated by thermal elimination reactions. For 
instance, base-catalyzed conjugate addition of allyl alcohols to phenyl vinyl sulfone 
generates 2-(phenylsulfinyl)ethyl ethers, which can undergo elimination at 200°C, 
and it is at this temperature that the [3,3] rearrangement proceeds. Allyl enol ethers 
have also been prepared by Wittig reactions using ylides generated from 
allyloxymethylphosphonium salts (Scheme 7). 
 
 
 
Scheme 7. Preparation of allyl enol ethers through the Wittig reaction. 
 
 
6 
 
 
 
1.1.3. Asymmetric Claisen rearrangement 
In order to make chiral Claisen rearrangement products using an asymmetric route 
there are several possibilities. If no external asymmetric induction is applied, the 
enantiomers can be separated via resolution but this method suffers from the 
disadvantage of losing half of the unwanted enantiomer, which is highly 
undesirable. The first option is to transfer chirality from either the allylic or vinylic 
fragment of the allyl enol ether to the chiral carbon through a complete [1,3]-
chirality transfer (remote stereocontrol), although other positions in the allyl enol 
ether substrate have also be used to transfer the chirality. Alternatively, more than 
one chiral center can be used to transfer the stereochemical information. The chiral 
allylic fragment can be obtained by such well known processes like the Sharpless 
asymmetric epoxidation5, enantioselective reduction of carbonyl compounds6and 
enzymatic processes.7 In the diastereoselective reaction proceeding through 
remote stereocontrol the chiral center is usually present present to position one 
and six (Scheme 8). 
 
Scheme 8. Diastereoselective reaction proceeding through remote stereocontrol. 
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Secondly, the asymmetric induction can be achieved through the use of a chiral 
auxiliary. A survey of literature reveals the prevalence of the chiral auxiliary in three 
main positions of the allyl enol ether (Scheme 9).  
 
Scheme 9. Use of chiral auxiliary for Asymmetric induction in Claisen 
rearrangement reaction. 
Thirdly, chiral catalyst can be used to achieve asymmetric induction. Although 
there are many reports in the literature for examples that use stoichiometric 
quantities of catalyst, the use of catalytic quantities has thus far not found 
extensive application and is limited to particular types of substrate class. In the 
former case, where stoichiometric amounts are needed has usually been used in 
the ester and amide enolate Claisen rearrangement. The ester or amide substrate 
is reacted with a strong base at low temperature, forming the allyl enol ether 
Claisen substrate in situ. Next, a Lewis acid together with the corresponding chiral 
ligand is added which coordinates with the oxygen of the in situ formed enolate 
(Scheme 10). One of the limitation of this reaction is an equimolar quantities of 
chiral Lewis acid complexes need to be added, which is necessary y because the 
metal complex binds more strongly to the carbonyl product than to the starting 
8 
 
 
 
material. Therefore, the reason for the scarcity of examples in the literature for 
reaction that employ catalytic quantities of Lewis acid.  
 
Scheme 10. Lewis acid catalyzed ester enolate Claisen rearrangement. 
 
1.1.4. Asymmetric catalytic Claisen rearrangement 
Overman et al.8 reported the first examples of a truly catalytic reaction of the 
conversion of allyl amidates into the corresponding carbamates employing chiral 
palladium catalysts. A series of chiral oxazoline substituted ligands were tested by 
Uozumi and Hayashi in the palladium (II)-catalyzed rearrangement of a N-(4-
(trifluoromethyl) phenyl)i substituted allyl imidate (Scheme11). 
 
Scheme11. First example of catalytic conversion of allyl amidates to carbamates. 
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Achiral Al (III) Lewis acids are able to accelerate the aliphatic Claisen 
rearrangement, however, their applicability as catalysts is prevented by product 
inhibition.10 Al (III), B (III), and Mg (II) chiral Lewis acid complexes have been 
efficient for the asymmetric reaction but have not found applicability for a catalytic 
version of the reaction.11 Interestingly, quinine was used in more than 
stoichiometric amounts as a chiral base to effect an asymmetric Ireland-Claisen 
rearrangement (Scheme 12).12 
A small number of catalytic achiral metal catalysts that speed up the Claisen 
rearrangement have been reported, for example Pd(II) complexes,13 lanthanide 
(III) complexes 14and TiCl415. In both metal promoted and metal catalyzed Claisen 
rearrangement reaction, substituents on allyl enol ether have a dramatic effect on 
the rate of rearrangement. Lewis acid catalysts are substrate specific, if one metal 
Lewis acid is found to catalyze the Claisen rearrangement of a specific allyl enol 
ether substrate, this does not make it suitable as a catalyst for a varied range of 
allyl enol ether substrates. Consequently, substrate structure, the nature of the 
Lewis acid and associated ligands along with the structure of the product have to 
be adjusted carefully to achieve effective metal catalysis and avoid side reactions 
such as ionization 16 and/or product inhibition of the catalyst. 
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Scheme 12. Asymmetric Claisen rearrangements by Al (III), Mg (II), quinine and 
Boron catalyst. 
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In 2001 Hiersemann et al. reported a catalytic version of the Claisen 
rearrangement of simple allyl enol ether, the findings that several metal triflates, 
such as Cu(OTf)2, Lanthanide(OTf)3 and Sc(OTf)3, catalyzed the Claisen 
rearrangement of 2-alkoxycarbonyl-substituted allyl enol ethers.17 The asymmetric 
version of the similar transformation catalyzed by Cu2+ complexes followed soon 
afterwards. 18 The recognition of Cu(OTf)2 as an capable catalyst led to the report 
of the very first asymmetric catalytic Claisen rearrangement using the well 
celebrated chiral copper(II) bis(oxazolines) (Figure13).  
N
Cu
N
OO
TfO OTfR R
R = Ph 1
R = t-Bu 2
R = Ph 3
R = t-Bu 4
N
Cu
N
OO
TfO OTfR R
2
2 SbF6
 
Figure 1 . Chiral copper (II) bis(oxazolines) catalysts for asymmetric Claisen 
rearrangement. 
By means of this method enantiomeric excess values were reported in the range 
80-90%. Additional studies into the substrate scope of the Claisen rearrangement 
with the aforesaid 2-alkoxycarbonyl-substituted allyl  enol ethers led to the 
discovery that the known bench stable [Cu{(S,S)-t-Bu-box}](H2O)(SbF6)2 (Figure 1) 
complex combines efficient enantioface-differentiating capacity and high Lewis 
acidity, proving to be a powerful catalyst for the asymmetric Claisen rearrangement 
(Scheme 13).  
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O
i-PrO O
TPSO
TPS = t-BuPh2Si
cat. 4 (10 mol%) 
4 A MS, CH2Cl2, rt, 1.5 h
98%, 99% ee O
O
OiPr
TPSO
 
Scheme 13. Lewis acid catalyzed rearrangement with [Cu{(S,S)-t-Bu-
box}](H2O)(SbF6)2 complex . 
Further expansion of this work led to a report of the catalytic asymmetric Claisen 
rearrangement of 2-alkoxycarbonyl-substituted allyl enol ethers containing two 
stereogenic double bonds (Scheme 14).18b The results clearly demonstrated a 
remarkable influence of the configuration of the double bond of the allyl enol ether 
and the nature of the catalyst on the stereoselectivity of the rearrangement. 
Generally, use of an allyl enol ether containing an E-configured allylic double bond 
frequently provides decreased diastereoselectivities 18b.  
O
i-PrO O
R1
R6
cat. 4 (10 mol%)
4 A MS, CH2Cl2, rt
O
O
OiPr
R
O
O
OiPr
R
R
yield: 97-99%
ee: 74-99%
R1 = H, OBn, OTPS, CH2OBn
R6 = Et, OBn, OTPS  
Scheme 14. Catalytic asymmetric Claisen rearrangement with catalyst 4. 
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From the outcome of earlier studies on the thermal Claisen rearrangement, the 
authors propose the catalytic cycle for the Cu(box)-complex catalyzed reaction 
(Scheme 15) proceeds via a highly polarized pericyclic transition state of 
considerably lower activation energy (Figure 2). 
O
ORO
R
R
N
Cu
N
O
Ot-Bu
t-Bu
2+
Cu(box)2+
O
RO
R1
O
R
O
RO
R1
O
R
Cu(box)
2+
O
RO
R1
O
R
Cu(box)
2+
O
RO
R1
O
R
Cu(box)
2+
 
 
Scheme 15. Proposed catalytic cycle for the (S,S)-4-catalyzed Claisen 
rearrangement. 
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Figure 2. Transition state for the (S,S)-4 catalyzed Claisen rearrangement. 
 
In 2008 the Jacobsen group detailed the first catalytic asymmetric Claisen 
rearrangement with a hydrogen-bond donor catalyst. 19 Guanidinium catalysts 
were ineffective for asymmetric induction, while high enantioselectivities were 
attained in the reaction carried out between 20oC and 40°C over a period of several 
days with a guanidinium BArF catalyst 5 (Scheme 16).Despite the fact that the 
guanidinium BArF catalyst 5 is virtually insoluble in the solvent, use of 
dichloromethane or benzene resulted in slightly reduced enantioselection, while 
no catalytic effect was noticed with ethereal solvents such as TBME or Et2O. 
Optimal rates and enantioselectivities for the reaction were found in n-hexanes. 
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MeO
O
R1
O
R2
R4
R3
catalyst 5 (20 mol %)
22-40 oC, 5-14 d
hexanes
MeO
O
O R1
R3 R4
R2
up to 92% yield, 96 % ee
N
H
N
H
NH2
+
N PhNPh
BArF
BArF =
B
CF3
CF3 4
5  
Scheme 16. Catalytic Claisen rearrangement with chiral guanidinium catalyst. 
Simultaneously with the report by Jacobsen, the Kozlowski group 20 reported that 
allyloxy-indoles are a new class of substrates that permit catalytic yield. By using 
palladium complexes, they reported on the first asymmetric catalytic Meerwein-
Eschenmoser Claisen rearrangement, which engages the transformation of 2-
amino allyl enol ethers to γ,δ-unsaturated amides. The formation of the 
intermediate hemiaminal usually requires forcing conditions, making the reaction 
incompatible for asymmetric catalysis in normal cases. Despite the high activation 
energy typically required for dearomatization accompanying the rearrangement, 
indole containing Claisen subtrates were used for the reaction.  The substrates 
were suitable to catalysis probably due to the nucleophilic nature of the C-3 carbon 
of the indole ring (Scheme 17). The reaction was suggested to continue via a chair-
like transition state, with both the oxygen of the allyl enol ether and the carbonyl 
oxygen of the ester group binding to the Pd(II) catalyst (Figure 3). 
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Scheme17. Catalytic Meerwein-Eschenmoser Claisen rearrangement. 
 
 
Figure 3. Proposed transition state for the Meerwein-Eschenmoser Claisen 
rearrangement. 
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In 2012 Marisa Kozlowski et al 21reported the first asymmetric synthesis of allenyl 
oxindoles and spirooxindoles by the catalytic enantioselective Saucy-Marbet 
Claisen rearrangement, specifically, the transformation of propargyl ethers to 
afford β-substituted allenyl carbonyls (Scheme18). The reaction generates two 
classes of chiral oxindoles containing newly formed quaternary centers: allenyl 
compounds and spirocyclic lactones through a tandem rearrangement (Scheme 
19). The tandem reactions of silyl-substituted substrates allow fast assemblage of 
complex spirooxindoles, an essential class of biologically active structures in one 
procedure. The findings offer a promise for the general use of alkynyl enol ethers 
in catalytic, asymmetric rearrangement reactions, providing an alternative route to 
valuable allenes. 
N
H
CO2R
1
1) NCS
NN MeMe
2) Cl3CCO2H
HO
R2
N
H
R1O2C
O
R2
L*Pd(SbF6)2
N
H
R1O2C
OR3R3R
3
88-98% ee
20 examples
R1 = Me, Et, Bn, CH2CF3
R2 = H, tBu, MIDA, Ar, TMS, TES, TBS, TIPS
R3 = H, 5-OMe, 7-OMe, 5-Br, 7-Me
R2
 
Scheme 18. Catalytic Saucy–Marbet Claisen rearrangement.  
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Scheme19. Pd(II) catalyzed tandem formation of a spirocyclic oxindole. 
1.2.1. Hydroxyarylacrylate as a prochiral carbon center. 
In Professor Hossain’s lab we have access to a very interesting molecule, e.g., 
Hydroxyarylacrylate 6 which can be synthesized from simple aldehyde in one step 
(Scheme 20) 22. This molecule furnished with three different functional groups that 
can be transformed into valuable intermediate molecules such as Indole 3-
carbaldehyde 23, bezofuran 24 or Ibuprofen 25 in one or two steps (Figure 4).   
R
O
+ N2CHCO2Et
10 mol% Lewis acid
or Bronsted acid
(HBF4.OEt2)
R
CO2Et
OH
Fe
OC
CO
O
BF4
6  
Scheme 20: BrÖnsted acid catalyzed formation of hydroxylarylacrylate from 
substituted benzaldehydes. 
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Figure 4. New compounds that were constructed from hydroxylarylacrylates. 
 
 
 Because of its enolic double bond hydroxyarylacrylates seems to be an attractive 
prochiral center, hence allowing for the possibility of asymmetric synthesis under 
phase transfer catalysis conditions (Scheme 21). 
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Scheme 21. Hypothetical Phase Transfer catalyzed synthesis of Quaternary 
center. 
However our initial approach for the construction of an α-aryl quaternary carbon 
starting from arylhydroxyacrylates involved direct alkylation of the enolate of 3 with 
an alkyl halide. Alkylation with bases such as solid or aqueous KOH gives 
exclusive O-alkylation (Scheme 22), whilst the attempted alkylation with solid or 
aqueous NaOH only gave a small amount of C-alkylated product (ca 20% with allyl 
iodide). We believe that O-alkylation is much more favored since the high degree 
of conjugation present in the acrylate 3, preserved in O-alkylation, is however 
disrupted in C-alkylation. We have screened various electrophiles for the reaction 
[allyl iodide, allyl bromide, ethyl iodide, 4-(trifluoromethoxy)benzyl bromide] and 
solvents (toluene, dichloromethane, THF); all reactions with KOH under any 
conditions provided exclusively the O-alkylated product. In the case of using 
NaOH, increasing the polarity of the solvent by using THF resulted in even lower 
amounts of C-alkylated product. An electrophile with a softer leaving group (allyl 
iodide instead of allyl bromide) resulted only in a slightly greater yield (by 5%) of 
C-alkylated product. 
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The allyl enol ether Claisen substrates can be made through a practical one-pot 
protocol (Scheme 22) whereby the in situ formed 3-hydroxy aryl acrylate is reacted 
with allyl bromide to provide the O-alkylated products in mostly good yields. 
 
Scheme 22 . One-pot synthesis of O-alkylated allyl enol ethers. 
 
1.2.2. Thermal Claisen rearrangement of allyl enol ethers derived from 
3-hydroxy aryl acrylates 
In our attempt to make direct C-alkylation of hydroxyarylacrylate we obtained 
predominantly O-alkylated product. However, we realized that the O-allyl enol 
ethers were suitable candidates for a Claisen rearrangement that would afford an 
indirect C-alkylation leading to the desired α-aryl quaternary carbon. (Scheme 23, 
Table 1).The O-alkylation of acrylates 3 was carried out in dichloromethane using 
allyl bromide under phase transfer catalysis conditions (using either Bu4NI or 
Bu4NBr) and aqueous or solid KOH as base. Reactions carried out in the absence 
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of a phase transfer catalyst resulted in very low yields of product.  The yield of C-
allylated products seems to be hindered by the presence of electron withdrawing 
substituents (Entries 3 and 5, Table 1). 26 
 
Scheme 23. Thermal Claisen rearrangement of O-alkylated substrates. 
Table 1. Formation of O-alkylated and C-alkylated products. 
Entry Ar Yield 7 (%) Yield 8 (%) 
1a,b C6H5 71 89 
2a,b 4-MeC6H4 80 85 
3a,b 2,4-Cl2C6H3 82 69 
4a,b 4-MeOC6H4 66 88 
5a,b 4-FC6H4 65 55 
6a,b 
5-Br-2-
MeOC6H3 
72 90 
7a,b 4-t-BuC6H4 84 91 
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1.3.1. Synthesis of quaternary carbon center by Claisen 
rearrangement 
   With the knowledge that allyl enol ethers derived from 3-hydroxyarylacrylates are 
possible precursors for the thermal Claisen rearrangement, we set out to 
investigate whether the catalytic asymmetric Claisen rearrangement was a viable 
procedure (Scheme 24).  
 
 
 
Scheme 24. Hypothetical asymmetric Claisen rearrangement of allyl enol ethers.  
1.3.2. Significance of quaternary stereocenters and asymmetric 
catalysis 
The creation of all carbon quaternary centers with enantiocontrol remains one of 
the most challenging and demanding topics in the organic synthesis of natural 
products. In the chemical sense the biological world can be regarded as a chiral 
world. Usually it happens in nature that one enantiomer shows biological activity 
whereas the other enantiomer does not. A large number of biologically active 
natural products contain quaternary carbon centers (Figure 5). Interest in 
asymmetric synthesis of these natural products in an optically active form is 
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reflected in the articles published recently. Due to their importance in 
pharmaceutical applications several new methods were developed for the 
construction of quaternary carbons. Recent reviews have also highlighted 
significant contributions in this research area. 27 Asymmetric synthesis of 
quaternary carbon center can be classified into two types, enantioselective and 
diastereoselective synthesis. Enantioselective reaction is carried out on an achiral 
molecule using an enantioselective reagent or catalyst. On the other hand, in a 
diastereoselective synthesis, chirality is transferred to a prochiral center of the 
same substrate. 
 
Figure 5. Natural products containing chiral quaternary carbon center.  
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1.3.3. General considerations in the formation of quaternary 
stereocenters via asymmetric catalysis 
Non-catalytic formation of quaternary stereo centers involves harsh reaction 
conditions such as high temperatures and long reaction times. For this reason 
stereoselectivity of a reaction is adversely affected, but metal catalysis or 
organocatalysis allows for much milder reaction conditions, such as low 
temperature and thereby offers improved stereoselectivity of a reaction.  Most 
reactions have some limitations in their substrate scope, in the case of asymmetric 
reactions this problem is most relevant 28,29. 
Minor changes in the substrates structure can lead to significant changes in 
stereoselectivity, the worst case scenario is loss of stereocontrol with the change 
in substrate structure. It is common to most of the asymmetrically catalyzed 
reactions that they suffer from these limitations on the “partner combinations”. 
Subtle changes in the structure of the catalyst may led to unexpected changes in 
stereoselectivity. Other factors such as choice of solvent and temperature also 
have an important effect on the stereoselectivity of a reaction. Therefore, in order 
to find an optimum reaction condition for better stereoselectivity and improved 
yield, extensive screening of reaction conditions has to be carried out. 
Occasionally asymmetric catalysis will lead to suitable results for only a few 
substrates, and specific reaction conditions may need to be found in other cases. 
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1.3.4. General reaction classes for formation of quaternary 
stereocenters. 
There are  two main classes of catalytic processes for the generation of quaternary 
stereocenters: via metal and Lewis acid catalysis or by organocatalysis. Lewis acid 
catalyzed asymmetric quaternary center formation reaction has been successfully 
achieved for the following reaction types: 1,3-dipolar [3+2] cycloadditions, the 
synthesis of β-lactams via overall [2+2] cycloadditions, cyclopropanations, Diels-
Alder reactions, Michael additions, the alkylation of tributyl tin enolates, Michael 
additions with hard nucleophiles, copper catalyzed SN2’ allylation, reactions with 
carbonyl and imine electrophiles, metal catalyzed diene and enyne cyclizations, 
rhodium catalyzed C-H insertions and Claisen rearrangements 28.  The reactions 
that take place through organometallic protocols such as oxidative addition-
reductive elimination processes are intramolecular Heck reactions, vinylation and 
α-arylation reactions of ketones and lactones, and of course allylic alkylation via 
palladium π-allyl complex intermediates 28. 
Literature survey reveals that the majority of reactions involving the synthesis of 
quaternary stereocenters involve cyclic systems. For instance, in the review done 
by Marco Bella 29 on the organocatalytic formation of quaternary stereocenters out 
of a total of twenty-eight examples of Michael adducts containing quaternary 
carbon centers, only six different acyclic substrates were used. The use of acyclic 
substrates is much fewer in case of the asymmetric decarboxylative allylic 
alkylation (DAAA), and for some reaction classes there are none 30. Because of 
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the challenge of an increase in the number of degrees of freedom linked with 
acyclic structures there is a predominance of cyclic substrates in the literature. 
In 1971, an intramolecular aldol cyclization of the achiral triketone using an 
optically active amino acid as a catalyst was reported by Eder et.al. Treatment of 
substrate triketone with (S)-proline in acetonitrile afforded good yield and optical 
purity. Detailed studies on the dilution effect on (S)-proline indicated a three-
centered hydrogen bonded structure as transition state. This cyclization was 
extended to the acyclic ketone; although enantiomeric excess was moderate, 
interesting solvent effects were observed in this reaction(Scheme 25) 31. 
(CH2)n
O
O
O
(CH2)n
O
O
CH3CN
(S)-proline
n = 1,2 n = 1,2  
Scheme 25: (S)-Proline catalyzed aldol cyclization of triketone. 
 
  Figure 6. Proposed transition state of proline catalyzed reactions. 
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Shiro et al 32 reported the Claisen rearrangement of the optically active secondary 
alcohol center to produce in 51 % yields with 100% intramolecular chirality transfer. 
They achieved this result by treating alcohol with N,N-dimethylacetamide dimethyl 
acetal in refluxing o-xylene proceeded via intermediate (Scheme 26). 
 
Scheme 26. Claisen rearrangement of optically active secondary alcohol. 
Carbon-carbon bond formation using chiral palladium catalysts has been a 
particularly active field in recent years.  Buchwald reported 33 the highly 
enantioselective Pd-catalyzed intermolecular coupling of oxindoles and aryl and 
vinyl bromides facilitated by a biaryl monophosphine ligand that contains two 
sources of asymmetry. They also found that KenPhos and (iPr)2MOP promoted 
the coupling of 1,3-dimthyloxindole with 3-bromoanisole in the presence of 
TMEDA.PdMe2 and NaOtBu in good yield and promising ee (Scheme 27). 
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Scheme 27. Pd-catalyzed enantioselective α-arylation of 1,3-dimethyloxindole 
with a biaryl monophospine ligand. 
Enantioselective synthesis of quaternary center also has been reported by using 
Michael addition reactions, phase transfer catalyst system and of course using 
different metal catalyst system. Most of these reactions are substrate specific and 
further developments are needed in catalyst preparation and selectivity. 
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CHAPTER II: ASYMMETRIC SYNTHESIS OF QUATERNARY 
CARBON CENTERS  
2.1. Catalytic asymmetric Claisen Rearrangement of allyl enol ether 
obtained from 3-hydroxyarylacrylates 
Because of our success in thermal Claisen rearrangement of O-allylated aryl 
acrylate 7, we decided to pursue the asymmetric version of the same reaction by 
using chiral Lewis-acid catalyst. Towards that end, first of all, screening of 
organometallic Lewis acids and solvents are needed for the activation of allyl enol 
ether at room temperature. 
Inspired by the report by Kozlowski of the Meerwein-Eschenmoser Claisen 
rearrangement we assumed that the transition state for the rearrangement of allyl 
enol ethers obtained from 3-hydroxy aryl acrylates should be extraordinarily similar 
to the one reported by Kozlowski. We decided to try the Pd2+ Lewis acid catalyzed 
Claisen rearrangement as reported by Kozlowski 28 b,c. 
The Pd2+ catalyst complex was prepared by displacing chloride from Pd(BINAP)Cl2 
complex via a displacement reaction with AgSbF6 to form the corresponding SbF6- 
complex. Weakly coordinating counter ion (SbF6-) was chosen to increase the 
Lewis acidity of the metal complex. The reaction precipitated out a white AgCl, 
which was then filtered off through a PTFE filter (Scheme 28). 
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PdCl2(CH3CN)2 +  BINAP Pd
Cl
Cl
P
P
Ph
Ph
Ph
PhDCM
24 h, rt
2 AgSbF6
DCM, 3h
rt
Pd
P
P
Ph
Ph
Ph
Ph
2
+ 2 AgCl (s)2 SbF6
100% yield
10
9
 
Scheme 28. Synthesis of [Pd(BINAP)](SbF6)2 Lewis acid. 
 
H O
[Pd(BINAP)](SbF6)2 10(1 eq.)
DCM, 24h, rt
CO2Et
OH
CO2Et
 
Scheme 29. Attempted [Pd(BINAP)](SbF6)2 catalyzed Claisen rearrangement. 
Our experimental data suggests that asymmetric Claisen rearrangement with 
[Pd(BINAP)](SbF6)2 was ineffective, furthermore the metal was found to cleave the 
allyl-oxygen bond of the substrate forming 3-hydroxyarylacrylate (Scheme 29).  
Most probably, the oxygen of the allyl enol ether binds to the Pd2+ catalyst, and the 
bond between the oxygen and the allylic carbon is then cleaved with ease during 
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the work-up when the reaction mixture is passed through a silica plug (Scheme 
30). 
 
Scheme 30. Proposed mechanism for cleavage of oxygen-allylic carbon bond. 
Next we thought that other Lewis acids such as Cu2+ might avoid the problem of 
the enol oxygen-allylic carbon bond cleavage. The first use of chiral bis(oxazoline) 
ligands for the Lewis acid catalysed Claisen rearrangement resulting in excellent 
enantiomeric excesses was reported in 2004 by Hiersemann and coworkers. In 
our initial attempt, we used Cu(TfO)2 (1 eq) as a Lewis acid catalyst  in  DMF.  No 
product formation was observed even after 72 h, and we believe DMF deactivated 
the Cu2+ catalyst. 
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 We then synthesized a Cu(box)2+ complex, where Cu(box)Cl2 complex  is first 
formed, and the chlorides are then replaced with SbF6- via a displacement reaction 
with AgSbF6 to form the desired Cu2+ catalyst (Scheme 31). 
N
O
N
O
CuCl2    +
DCM, rt
24 h
N
O
N
O
Cu
Cl Cl
N
O
N
O
Cu
2
2 SbF6 + 2 AgCl (s)
2 AgSbF6
DCM, 3h
[Cu(box)](SbF6)2
11
12  
Scheme 31. Formation of [Cu(box)](SbF6)2 Lewis acid complex 12. 
With Cu2+ catalyst no product formation was observed via Claisen rearrangement 
at room temperature. We the removed the solvent under N2 and dry 1,2-
Dichloroethane was added to the reaction mixture. It was then heated to 60 oC and 
a small amount of C-alkylated product (29%) was observed in the NMR analysis 
of a crude product. Another catalyst [Cu(box)](OTf)2 was made by the addition of 
Cu(OTf)2 to 1 eq. of box ligand bearing the more strongly coordinating triflate 
counter ion. This counter ion may decrease the Lewis acidity of the catalyst and in 
turn decrease decrease the probability of enol oxygen-allylic carbon bond 
cleavage. Unfortunately, in this case also no product was formed at both room 
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temperature and under refluxing CHCl3 condition. However, this time the cleavage 
product (acrylate) was not formed which seems to point out that Cu2+ catalyst 13 
is a weaker Lewis acid (Scheme 32).  
CO2Et
H O
[Cu(box)](SbF6)2 12
DCM, rt
24 h
29% yield
C-alkylated
(NMR)
1,2-DCE
60°C
on
No Rxn
CO2Et
H O
[Cu(box)](OTf)2 13
CHCl3, rt
24 h
No Rxn
reflux
No Rxn
 
Scheme 32. Attempted Claisen rearrangements using Cu2+ complexes 12 and 13. 
Along with these catalyst in our group Eduardo tried other Lewis acid catalysts for 
asymmetric Claisen rearrangement of compound 7. In most cases no reaction was 
observed except for catalyst 12 (entry 11, Table 2). 
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Table 2. Attempted Claisen rearrangement with Lewis acids. 
 
Entry Metal Ligand Product Temp.( oC) 
1 Zn(OTf)2 
Box NR rt 
2 
Zn(SbF6)2 Box NR rt 
3 
Ni(SbF6)2 BINAP NR rt 
4 
PdCl2(CH3CN)2 - 6+7 rt 
5 
Pd(dppf)Cl2·CH2Cl2 - NR rt to 50 
6 
BF3·OEt2 - 6+7 rt 
7 
Fe(SbF6)2 PyBox NR rt 
8 
[Rh(COD)Cl]2 (R,R)-L3 NR 50 
9 (Cp*RhCl)2 - NR rt to 50 
10 Cu(SbF6)2 Box NR rt 
11 Cu(SbF6)2 Box 8 (29%) 60 
NR = No Reaction. 
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2.2. Metal catalyzed Asymmetric Allylic Alkylation for the synthesis of 
quaternary stereocenter. 
Asymmetric allylic alkylation has been known to be an alternative for Claisen 
rearrangement. After our initial attempt to convert allyl enol ether compound 7 to 
quaternary aldehyde 8 in an asymmetric fashion, we moved to a Pd(0)-catalyzed 
asymmetric allylic alkylation protocol. This reaction can be broadly classified into 
two categories, namely intermolecular and intramolecular asymmetric allylic 
alkylation. 
2.2.1 Intermolecular Pd-catalyzed asymmetric allylic alkylation 
reaction 
Recently we published the first example of the intermolecular palladium-catalyzed 
AAA of hydroxyacrylates 34 which enabled us to synthesize all-carbon α-aryl 
quaternary aldehydes in good yield and enantioselectivity. In this protocol we 
developed a new intermolecular Pd-AAA reaction, in which hydroxyarylacrylates 
are used as nucleophiles for the first time to produce acyclic all-carbon quaternary 
aldehydes. Substituted hydroxyarylacrylates were used as nucleophiles and 
provided α-allylated α-aryl all-carbon quaternary aldehydes in high yields with high 
enantioselectivities. We believe this methodology possesses potential to be 
investigated further and utilized for the synthesis of a vast number of natural 
products containing α-aryl quaternary stereocenters (Scheme 33). 
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Yield: 75 - 99%
 ee    : 75 -94%  
Scheme 33. Pd-catalyzed intermolecular AAA reactions of hydroxyarylacrylates 
with allyl acetate. 
 
Tanaka et al reported35 palladium-catalyzed asymmetric allylic alkylation using 
novel pyrrolidinyl-containing chiral aminophosphine ligands possessing hydroxyl 
groups in the terminal of the side chain. They have reported excellent yield and 
%ee for the asymmetric allylic alkylation reaction (Scheme 34). 
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Scheme 34. Pd-catalyzed intermolecular asymmetric allylic alkylation using chiral 
amino phosphine ligand. 
 
2.2.2. Intramolecular AAA reaction for the synthesis of quaternary 
stereocenter 
 
 Since the first example, reported by Trost in 1977, 36 intermolecular AAA has 
undergone a remarkable development, and is now a well established method. In 
contrast, to the best of our knowledge, successful carbanion based intramolecular 
AAA have been reported only by the groups of Yamamoto and Tsuji, Genet, 
Pfaltz,Trost and Ready, with only Genet being able to concurrently control two 
stereogenic centers in this step 37. The paucity of successful examples in this field 
may stem from the intrinsic complexity of the reaction mechanism. Indeed in a 
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classical benchmark intermolecular AAA, the enantiodiscriminating step is the C-
C bond formation, due to the Cg symmetry of the ƞ3-allyl moiety. On the other hand, 
the scenario is more complicated in an intramolecular AAA, wherein the oxidative 
addition or the C-C bond-formation step can be the enantiodiscriminating event, 
dependent on relative kinetics 38. 
In 2000, Trost reported 39 Pd-catalyzed asymmetric O-alkylation of 3-substituted 
cyclic 1,2-diketones. This O-alkylated product then undergoes further 
rearrangement to give C-alkylation product at 3 positions, thereby creating a 
quaternary stereocenter. The fact that 3-substituted cyclic 1,2-diketones exist as 
single tautomeric species raised the prospect of an asymmetric synthesis of  
cycloalkenones. This was achieved by decarbonylative intramolecular AAA-
Claisen rearrangement protocol. The chirality transfer in a Claisen rearrangement 
was examined in the case of the cyclic substrate, thermal process (>110 oC) was 
found to be ineffective with a great deal of ionization. Classical Lewis acids such 
as Hg(OAc)2 and Al(Me)2Cl as well as PdCl2.(CH3CN)2 gave no reaction or 
cleavage of the allylic ether bond. Lanthanide triflates such as lanthanum and 
europium triflate were  proved too reactive. Finally they found that the FOD ligand 
complexes of the lanthanides are effective and among the lanthanides Ho is the 
most effective catalyst. Therefore, use of 10 mol % Ho(fod)3 in a minimal amount 
of chloroform at 50-80 °C was adopted as the standard protocol for Claisen 
transformation( Scheme 35). 
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 Scheme 35. Asymmetric O-alkylation of 1,2-diketones followed by Ho(fod)3 
catalyzed Claisen rearrangement.  
In 2002 Trost reported intramolecular palladium-catalyzed allylic alkylation to give 
cyclized quinuclidinones 40, which is an important building block for the synthesis 
of quinolone Cinchona alkaloids. The mechanism of this reaction was elucidated 
and found to consist of ligand matched ionization of carbonate substrate, π-allyl 
equilibration, and then finally nucleophilic attack. They reported no solvent for the 
reaction but various additives were found to have a dramatic effect on the reaction 
and Eu(fod)3 had a profound impact on reactivity and reversed the 
diastereoselectivity.  Trost group presented an intra-molecular Pd-catalyzed AAA 
to generate [2,2,2] bicycles in good enantio- and diastereoselectivity. This could 
be a route for the asymmetric synthesis of quinine and quinidine from the 
cyclization of prochiral nucleophile β-keto esters (Scheme 36). 
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Scheme 36. Pd-catalyzed AAA reaction of β-keto esters in formation of 
bicycle[2,2,2] octan-2,3-diones and quiniclidin-2-ones reported by Trost. 
 
In 2006 Bandini M. reported 41  a highly enantioselective synthesis of tetrahydro-
β-carbolines and tetrahydro-γ-carbolines via Pd-catalyzed intramolecular allylic 
alkylation. Pictet-Spengler reaction still represents the primary route to the 
preparation of the biologically active β-carbolines, intramolecular AAA could be an 
alternative to that. This group also reported allylic alkylation as an substitute 
procedure for the conventional Friedel-Crafts reaction.  
Among the chiral promoters employed they found that the DPPBA-based Trost 
ligands furnished the highest level of regio- and stereoselectivity.  The excellent 
enantiomeric excess suggest this strategy as a valuable candidate for the 
preparation of stereochemically defined polycyclic aromatic compounds. 
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Scheme 37. Synthesis of 4-vinyl tetrahydro-β-carbolines via Pd-catalyzed 
intramolecular AAA reaction. 
 
Bantreil et. al. employed42 diphosphine MeoBIPHEP ligand with Pd(0) catalyst for 
the synthesis of optically active pyrrolidine system. The reaction proceeded 
through a basic phase transfer catalyst system that helped in enolization process, 
whereas Pd catalyst replace actetate leaving group easily formed π-allyl complex 
with the substrate (Scheme 38). 
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Scheme 38. Intramolecular allylic alkylation using R-MeOBIPHEP ligand. 
 
Recently Huo et. Al published 43 an enantioselective synthesis of 2,3-disubstituted 
indanones by an intramolecular Pd-catalyzed AAA with a  hard carbanion as a 
nucleophile (Scheme 39). They have experimented only on two P,N-ferrocene-
based SIOCPhox chiral ligands, ee was higher with (Sphos, Ra)-SIOCPhox than 
with (Rphos, Ra)-SIOCPhox. In their optimization study, it was found that O-
alkylation is a more favorable process to form 5-membered ether than 5-
membered cyclic ketone formation. They overcame this chemoselectivity issue by 
using tert-Butanol as a solvent and LiOH.H2O as a base. Both base and solvent 
were found to have an effect on selectivity.  Using diethyl phosphate as a more 
stable substrate under basic condition increased yield of the reaction to a great 
extent. In summary, using SIOCPhox chiral ligand Hou group has achieved a Pd-
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catalyzed intramolecular reaction with high diastereo- and enantioselectivity 
(Scheme 39). 
 
 
Scheme 39. A Pd-catalyzed intramolecular AAA reaction affording 2,3-
disubstituted indanones with high diastereo- and enantioselectivity. 
 
The intramolecular palladium-catalyzed cyclization of the β-keto ester with 
Ferrocenyl ligand provided moderate yield and ee. 44 Other chiral ligands such as 
chiraphos and (S)-BINAP, gave poorer results both in yield and %ee (Scheme 40) 
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Scheme 40. O-allylation and rearrangement towards C-alkylation. 
 
2.2.3. Decarboxylative asymmetric allylic alkylation 
In Pd-catalyzed decarboxylated allylation Stolz group reported 45 the formation of 
quaternary stereocenter using Phox type ligand (Scheme 41). 
 
Scheme 41. Decarboxylative asymmetric allylic alkylation using (S)-t-Bu-Phox 
ligand. 
In 2010 Stolz group published another article 46 in nature chemistry describing the 
synthesis of all-carbon quaternary stereocenter by asymmetric α-alkylation of 
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ketones (Scheme 42). Readily available β-ketoesters were used as starting 
material. They have shown the formation of palladium enolate as a key 
intermediate for this type transformation which can be intercepted by acidic proton 
or another electrophile. 
 
Scheme 42. Decarboxylative asymmetric allylic alkylation using modified (S)-t-Bu-
Phox ligand. 
Using a different prochiral electrophile enolate-trapping has been extended to the 
synthesis of vicinal stereocenters (Scheme 43).  
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Scheme 43. Formation of vicinal stereocenter using DAAA protocol. 
In our group after unsuccessful attempt to induce enatioselectivity in catalytic 
Claisen rearrangement, E. Alberch pursued DAAA method to synthesize 
quaternary aldehyde 8 from hydroxyarylarylacrylate 6.  Recently we published a 
decarboxylative protocol 47 to get an alternate route to make compound 8. In this 
method, a stereoselective synthesis of carbonates derived from 3-hydroxy-2-aryl 
acrylates was devised that can form the Z- or E-stereoisomer in very high Z/E 
ratios (50:1 and 1:99, respectively). The stereochemical outcome depends on the 
choice of base, addition of TMEDA and reaction temperature. The Z- and E-
stereoisomers have different reactivities towards the DAAA reaction, with the E-
stereoisomer displaying both greater reactivity and enantiodifferentiation with 
chiral ligands. The DAAA of E-stereoisomer analogues takes place in excellent 
yields ranging from 96–99% and enantioselectivities ranging from 42–78% ee 
(Scheme 44). 
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Scheme 44. Pd (0) catalyzed Decarboxylative asymmetric allylic alkylation of allyl 
enol carbonates modified from hydroxy-arylacrylate 6. 
 
2.3. RESULTS AND DISCUSSION 
Inspired by the example reported by Trost and our experience with intermolecular 
and decarboxylative AAA reaction, we envisioned similar reaction conditions using 
Pd(0) as a metal source for the rearrangement reaction. In a preliminary approach 
with Pd(0) catalyst we proceeded with a Pd(PPh3)4 catalyzed reaction of allyl enol 
ether derived from 3-hydroxyarylacrylate in dichloromethane at room temperature. 
We found that allyl enol ether 7 underwent a Pd (0)-catalyzed rearrangement to 
give α-aryl quaternary carbon compound. As a Pd (0) source we found that both 
Pd(PPh3)4 and Pd2(dba)3.CHCl3 were equally effective in the catalytic 
transformation of O-allylated compound to products.   
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We then attempted a catalytic intramolecular asymmetric allylic alkylation of 7 
using DACH-Naphthyl Trost ligand (R,R)-L3 and Pd2(dba)3.CHCl3 in 
dichloromethane at room temperature. The reaction gave quantitative yield and 
30% ee (Scheme 45). 
 
 
NH HN
O
O
PPh2 Ph2P
( R,R)-L3
H O
COOEt [Pd2(dba)3.CHCl3] (2.5 mol%)
         (R,R)-L3 (6 mol%)
Solvent, Temp.
O
COOEt
H
7 8  
Scheme 45. Pd-catalyzed intramolecular AAA reactions of allyl enol ether. 
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2.3.1. Mechanistic investigation 
Having found our desired catalytic reaction we need to develop the reaction 
protocol.  To understand the mechanism of the reaction, we investigated the 
reaction by making crotyl vinyl ether 14 from the reaction of arylhydroxyacrylate 6 
and crotyl bromide under phase transfer catalysis (Scheme 46).  
 
CO2Et
H OH
Br
Bu4NI (20 mol %)
KOH (45% aq), DCM, rt
( 1.2 eq.)
CO2Et
H O
146
 
Scheme 46. Synthesis of O-crotylated acrylate 14. 
 
Reaction of this O-crotyl compound 14 with Pdo generated both product 15 and 16 
(Figure 7), whereas thermal Claisen rearrangement of crotyl phenylvinyl ether 
produced exclusively product 15 ( Scheme 47). 
 
O
COOEt
H
14 15
H O
COOEt
O-Crotylated hydroxyarylacrylate
Reflux
DMF , 6 h
100% Conversion
 
Scheme 47. Thermal Claisen rearrangement of O-crotylated substrate 14. 
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We believe formation of Pd-allyl complex is responsible for both products, where 
nucleophilic attack on π-allyl complex can occur in both ends.  Consequently the 
reaction formed product 16 ( 75% ) and  product 15 (15%) from the sterically more 
hindered site (Figure 7 ). 
PdCO2Et
H O
EtO2C
O H
CO2Et
OH
Pd
LL
LL
CO2Et
HO
O H
CO2Et
15
Deformylation
CO2Et
16
75%
15%
 
Figure 7. Pd(0) catalyzed reaction of O-crotylated substrate 14. 
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Based on this study we propose a reaction mechanism for intramolecular AAA 
reaction of allyl enol ether (Figure 8). In the first step the ligand substituted to form 
a chiral ligand bound active Pd(0) complex. Second is the oxidative addition and 
formation of metal allyl complex changing palladium oxidation state from Pd(0) to 
Pd (II). In the following step, enolate carbon nucleophile attacks onto the allyl 
complex forming C-alkylated product and lastly the incoming ligand approaches to 
the metal in elimination of quaternary carbon product and regeneration of active 
catalyst 
 
Figure 8. Proposed mechanism of intramolecular AAA reaction for allyl enol ether 
7 
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2.3.2. Optimization of catalytic rearrangement for the synthesis of 
quaternary aldehydes 
Ligand Screening: In order to optimize reaction conditions for better 
enantioselectivity we investigated different ligands and solvent at various 
temperatures. For our ligand screening we selected C2 symmetric Trost ligands 
and Phosphinooxazolines(PHOX) which are well-known for  Pd-catalyzed 
asymmetric allylic alkylation reactions. It was demonstrated from our studies that 
C2 symmetric Trost ligands (R,R)-L2, (R,R)-L3 (Figure 9) are more effective in 
enantiodiscrimination than the PHOX type ligands (S)-L2. Among the Trost ligands 
Dach-Napthyl Trost Ligand (R,R)-L3 is the most effective(Table 3, entry 8),  
Anden-phenyl Trost (R,R)-L4 gave only 30% ee, whereas with Dach-pyridyl ligand 
(R,R)-L4 there was no reaction at all(Table 3, entry 6,7 ).  
Table 3. Screening of Trost’s ligand 
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Entry Ligand Solvent Temp.(o
C) 
% Conversion %ee 
1. (R,R)-L2 Tol:Hex (1:1) rt 100 20 
2. (R,R)-L2 Tol:Hex (1:1) -20 100 30 
3. (R,R)-L1 Tol:Hex (1:1) rt 80 racemic 
4. (R,R)-L1 Tol:Hex (1:1) -20 80 20 
5. (R,R)-L4 Tol:Hex (1:1) rt No Reaction  
6. (R,R)-L4 Tol:Hex (1:1) -20 No Reaction  
7. (R,R)-L3 Tol:Hex (1:1) rt 95 35 
8. (R,R)-L3 Tol:Hex (1:1) -20 90 65 
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Figure 9 . C2 symmetric Trost ligands. 
Other ligands such as monophosphines, BINAP type (Figure 10) and Bis-
oxaziline(BOX) were also found to be less active in the transformation and in all 
cases they failed to induce  any enantioselectivity.  For BINAP and 
monophosphines ligands quantitative conversion is obsereved but they failed to 
induce enantioselectivity to the product. Results from the screening of chiral 
monophosphines and BINAP ligands are summarized in Table 4.  
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Table 4. Screening of ligands. 
H O
COOEt [Pd2(dba)3.CHCl3] (2.5 mol%)
                 L (6 mol%)
Solvent, Temp
O
COOEt
H
7 8  
 
 
 
 
Entry Ligand Temperature(oC) % Conversion %ee 
1. XPhos rt 100 racemic 
2. XPhos -20 100 racemic 
3. SPhos rt 100 racemic 
4. R-BINAP rt 100 racemic 
5. R-BINAP -20 100 racemic 
6. S-Tol-BINAP rt 100 racemic 
7. S-Tol-BINAP -20 100 racemic 
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PCy2
i-Pri-Pr
i-Pr
XPhos
PCy2
OMeMeO
SPhos
PPh2
PPh2
R-BINAP
P(Tol)2
P(Tol)2
S-Tol-BINAP  
Figure 10 . Monophosphine and BINAP ligands. 
Phox type ligands were reported to be an effective chirality inducing agent for 
asymmetric allylic alkylation and decarboxylative asymmetric allylic alkylation 
(DAAA) reactions. But in our reaction we found Phox ligands (S)-L2 (Figure 11) 
induce moderate enantioselectivity with high conversion (Table 5, entry 1,2). 
However, Box and other modified Phox ligand types were not effective at all in 
transfering chirality to the product. 
58 
 
 
 
PPh2
(S)-L2
N
O
FeP
Ph
Ph
N P
Ph
Ph
Methyl-BoPhozt-Bu-Phox
FeP
Ph
Ph
Ferrocene Phox
N
O
t-Bu
N
OO
N
Methylene bis-oxazoline
 
Figure 11 . Methyl-BoPhoz and Oxazoline ligands.  
Table 5. Bis-oxazoline (Box) and Phox type Ligand screening. 
 
 
Entry Ligand Temperature(oC) % Conversion %ee 
1. t-Bu-Phox (S)-L2 rt 100 20 
2. t-Bu-Phox  (S)-L2 -20 100 30 
3. Methyl-BoPhoz rt 100 racemic 
4. Methyl-BoPhoz -20 100 racemic 
5. Ferrocenyl Phox rt No Reaction  
6. Methylene Box rt No Reaction  
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Solvent study: 
In our ligand screening we found that ligand (R,R)-L3 demonstrated a high level of 
enantiodiscriminative sensitivity towards polarity of solvents and temperature 
changes of the reaction. The use of hexane/toluene solvent mixtures was 
previously reported by Stoltz, and it is thought that this very low polarity system 
increases stereoinduction by helping to form tight ion pairs through the formation 
of “solvent cages”. We thus reasoned that the combined effect of the formation of 
“solvent cages” by using low-polarity hexane/toluene (1:1) solvent and tightening 
the ligand pocket by switching to naphtholinker, (R,R)- L3, from the phenyl linker, 
(R,R)-L1, was instrumental in this dramatic increase in enantioselectivity.  
Experimental results showed solvent polarity played a major role in the reaction 
rate and enantioselectivity, for instance under similar condition %ee for the 
reaction in THF was 33% whereas in mixed solvent toluene:hexane(1:1)  %ee 
jumped to 65% ( Table 3, entry 8). We believe the ideal solvent polarity which 
afforded us with maximum yield and enantioselectivity for our parent system 
comes from mixed solvent toluene:methanol (50:1) (Table 2, entry 9). We believe 
a plausible explanation for this lies in the solubility and complex formation of ligand 
and metal. Nonpolar solvents help dissolving the ligand slowly to form the metal 
complex; and it has better interaction with the substrate enolate in ‘tight ion pair’ 
formation for a longer period of time during the course of the reaction.   
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Table 6. Solvent effect on the reaction. 
H O
COOEt [Pd2(dba)3.CHCl3] (2.5 mol%)
                 L (6 mol%)
Solvent, Temp
O
COOEt
H
7 8  
 
Entry Solvent Temp.(oC) % Conv. % ee 
1. Toluene:Hexane (1:1) rt 100 10 
2. Toluene:Hexane (1:1) -78 to rt 80 53 
3. Toluene:Hexane (1:1) -20 95 65 
4. Dichloromethane rt 100 racemic 
5. DMSO rt 80 18 
6. Acetonitrile rt 90 racemic 
7. THF -20 100 33 
8. Toluene -20 100 50 
9. Toluene:Ethanol (50:1) -20 100 70 
10. Toluene:Methanol (50:1) -20 100 75 
11. Toluene:Methanol (50:1) rt 100 30 
12. Toluene:t-Butanol (50:1) -20 90 33 
13. Toluene: IPA (50:1) -20 85 35 
14. Toluene:H2O (50:1) -20 80 35 
15. Toluene:H2O (50:1) rt 85 52 
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Temperature effect 
After ligand screening we investigated the effect of temperature on reaction 
rate and enantioselectivity, our results showed Temperature also has a 
profound effect in both yield and %ee. The reaction is found to be working 
best at -10 oC to -20 oC. At lower temperature i.e.,-40oC or -78 oC there were 
no reaction at all (Table 7. entry 6 and 7) and at 0oC or room temperature 
reaction rate was faster but resulted with reduced enantioselectivity (Table 
7, entry 1-3). 
Table 7. Effect of temperature on the asymmetric quaternary carbon 
formation. 
H O
COOEt [Pd2(dba)3.CHCl3] (2.5 mol%)
                 L (6 mol%)
Solvent, Temp
O
COOEt
H
7 8  
Entry Temp. 
( oC) 
Solvent Ligand %Conv. %ee 
1 rt Tol:Hex (1:1) DACH-
Naphthyl 
100 30 
2 rt Dichloromethane DACH-
Naphthyl 
100 racemic 
3 0 Tol:Hex (1:1) Phox 25 20 
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4 -20 Tol:Hex (1:1) DACH-
Naphthyl 
100 60 
5 -40 Tol:Hex (1:1) DACH-
Naphthyl 
No 
Reaction 
 
6 -78 Tol:Hex (1:1) DACH-
Naphthyl 
No 
Reaction 
 
7 -78 Tol:Hex (1:1) Phox No 
reaction 
 
8 -78 to rt Tol:Hex (1:1) DACH-
Naphthyl 
80 53 
 
Additives:  
In order to get optimum solvent polarity and help tight ion pair formation 
during the reaction we employed several additives. Addition of base has 
been reported to promote Pd-catalyzed alkylation reaction. We have tried 
several base such as triethyl amine, di-isopropylethyl amine, KOtBu, none 
of them were capable of producing better result ( Table 8, entry 10-14). 
Among the additives best results were obtained for phase transfer agent 
such as tetrabutyl ammonium iodide which gave 52% ee at -20 oC, and RbF 
afforded 50% ee( Table 8, entry 6 and 9). 
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Table 8. Effects of additive on the enantioselectivity. 
H O
COOEt [Pd2(dba)3.CHCl3] (2.5 mol%)
        (R,R)-L3 (6 mol%)
Toluene:MeOH (50:1), Temp
O
COOEt
H
7 8  
Entry Additives Temp. ( oC) % Conv. % ee 
1. LiBF4 rt 100 10 
2. LiBF4 -78 No Rxn  
3. NaOAc rt No Reaction  
4. NaOAc -78 No Reaction  
5. NBu4I rt 100 15 
6. NBu4I -20 100 52 
7. NBu4I -78 No Reaction  
8. NaClO4 rt No Reaction  
9. RbF -20 25 50 
10. KOtBu rt No Reaction  
11. KF rt No Reaction  
12. Net3 -78 No Reaction  
13. Net3 -40 No Reaction  
14 Di-isopropyl 
ethyl amine 
-20 100 15 
 
Finally optimized reaction condition involves (R,R)-L3 catalyst in mixed toluene-
methanol (50:1) solvent at -20 oC for 72 hours. This condition provided us with 95% 
conversion and 75% ee for the parent sytem (Scheme 48). 
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Scheme 48. Optimized reaction condition for asymmetric rearrangement reaction. 
Although we were able to get optical rotation of the compound 8 { [α]D27: = + 73.50 
(c = 0.082, EtOAc)} our attempt to crystallize it has been a failure. We tried to 
crystallize quaternary aldehydes by making it a solid hydrazone, but the reaction 
didn’t work, instead we observed deformylation of quaternary compound (Scheme 
49).  
 
Scheme 49. Attempted reaction for the formation of solid hydrazone. 
 
2.4. Scope of the reaction 
In order to determine the scope of this rearrangement reaction, a number of 
analogs were subjected to the newly optimized reaction conditions. Studies 
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showed that electron donating or electron withdrawing groups did not appreciably 
affect the yields of the products, but EWG favored enantioselectivity (8c, 8e Figure 
12). The reaction was also found to have steric effect; o-substituents have shown 
lower yield and enantioselectivity (8i, 8j Figure 12). Interestingly nitro variant of o-
allylated compound needed much polar solvent than our optimized solvent system, 
therefore THF was the solvent choice for compound 8j and 8m. Electron donating 
methoxy substituent was found to be notorious in the optimized reaction condition, 
they either deformylate or catalyst failed to induce enantioselectivity ( 8l, 8n, 8o, 
Figure 13).  However, our best result comes from the substrates with bulky 
substituent at the para position( 8f, Figure 12). Substituent with 5-Bromo, 2-
methoxy functional groups in the benzene ring provided best yield and %ee. 
Apparently the deleterious effect of methoxy groups  was minimized by the bromo 
functionality and made it a ideal substrate for the transformation (compare  8d and 
8l) . 
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Figure 12. Scope of Pd(0) catalyzed asymmetric rearrangement of allyl enol ether 
7. 
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Figure 13. Scope of Pd(0) catalyzed asymmetric rearrangement of allyl enol ether 
7. 
2.5. Summary and Future work:  
We have accomplished the first example of Pd(0) catalyzed Claisen type 
rearrangement with good % yield and enantioselectivity. We believe the reaction 
proceed through asymmetric allylic alkylation protocol. Further optimization is 
necessary for better enantioselectivity of important analogs which can be used for 
downstream synthesis. This method can utilized for the synthesis of α-aryl 
quaternary aldehydes.  These aldehydes have potential for the synthesis of 
quaternary carbon center bearing natural product, for instance, indole containing 
Horsefiline can be synthesized starting from o-nitroaldehydes (Scheme 50).. 
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Scheme 50. Synthesis of Horsfiline starting from substituted nitrobenzaldehyde. 
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CHAPTER 3.GENERAL METHODS AND EXPERIMENTAL  
3.1. Experimental Procedures 
a) General Considerations 
All reactions were performed under argon atmosphere in oven-dried glassware 
with magnetic stirring. Air and moisture-sensitive liquids and solutions were 
transferred via oven-dried, stainless steel syringe and were introduced into the 
reaction vessel through rubber septa. CH2Cl2 was distilled from calcium hydride.  
Other solvents used were distilled from sodium-benzophenone. Freshly distilled 
solvents were then degassed for Pd-catalyzed reactions by freeze-pump-thaw 
techniques under vacuum. Previously reported compounds were identified by 1H 
NMR (nuclear magnetic resonance) spectrum.  All new compounds were 
characterized by additional 13C NMR and high resolution mass spectroscopy. 
Analytic thin layer chromatography (TLC) was performed on silica gel plates 
(Merck 60F254) visualized either with a UV lamp (254 nm) or by using iodine 
chamber. Flash chromatography was performed using 40-60 µm silica gel 
(Silicycle). The eluent employed for flash chromatography is reported as 
volume/volume ratios. Organic extracts were dried over anhydrous Na2SO4. 1H 
and 13C NMR spectra were performed on a Bruker NMR at 300 and 75 MHz, 
respectively. 1H NMR data are reported as follows: chemical shift (δ) in parts per 
million (ppm) from tetramethylsilane as an internal standard (CDCl3 δ7.26 ppm), 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
integration. 13C data were reported as follows: chemical shifts (δ) are reported in 
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parts per million (ppm) from tetramethylsilane with the solvent as an internal 
indicator (CDCl3 δ77.16 ppm). Chiral HPCL analysis was performed using Waters 
1500 Series HPLC equipped with Regis Technologies Pirkle Covalent chiral 
stationary phase column. HPLC retention times of enantiomers were determined 
by comparison to racemic materials. Optical rotations were measured by Jasco 
DIP-370 digital polarimeter using 1 cm glass cells with a sodium 589 nm filter and 
are reported as [α]D27 , concentration (mol/L) and solvent.  High-resolution mass 
spectra were acquired by the University of Wisconsin Milwaukee Mass 
Spectrometry laboratory. 
b. Synthesis of (Z)-ethyl 2-aryl-3-hydroxyacrylates:  Compounds 6a-h was 
synthesized by using our published procedure.48 The identity of these compounds 
was confirmed by 1H and 13C NMR. 
c. Synthesis of (Z)-ethyl-3-(allyloxy)-2-arylacrylates (7): General Procedure. 
Ethyl 2-aryl-3-hydroxyacrylate3 (1.0–5.0 mmol) was dissolved in freshly distilled 
dichloromethane (5–10 mL) under nitrogen. Bu4NI (0.1 equiv.), allyl bromide (1.2 
equiv.), and potassium hydroxide (10 equiv.) were added, and the reaction mixture 
was stirred at room temperature until reaction completion was confirmed by NMR 
(Scheme 51). The reaction was quenched by adding saturated NH4Cl, and the 
aqueous layer was extracted with diethyl ether (2 × 25 mL). The organic extracts 
were combined and dried over Na2SO4. The organic layer was then passed 
through a silica plug and the solvent was removed by rotary evaporation. Pure 
product was isolated by column chromatography (5–10% ethyl acetate in pentane) 
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and identified by 1H NMR. 1H, 13C NMR and HRMS were applied to characterize 
the new compounds. 
CO2Et
H OH
10 eq KOH (s)
TBAI (10 mol%), 
allyl bromide
CO2Et
H O
R R
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Scheme 51. Synthesis of O-allylated compound 7. 
(Z)-Ethyl 3-(allyloxy)-2-phenylacrylate (7a). Yellow oil. HRMS: 233.1169 [calcd. 
for C14H16O3 (M+H): 233.1177]. 1H NMR (300 MHz, CDCl3): δ 7.67 (s, 1H), 7.45-
7.30 (m, 5H), 5.92 (m, 1H), 5.4 (d, J = 17.4 Hz, 1H), 5.3 (d, J = 10.5 Hz, 1H), 4.53 
(d, J = 4.0 Hz, 2H), 4.28 (q, J = 7.1 Hz, 2H), 1.30 (t, J = 7.1 Hz, 3H). 13C NMR (75 
MHz, CDCl3): δ 167.6, 157.6, 132.7, 132.4, 130.2, 127.6, 126.9, 119.3, 111.9, 
74.9, 60.2, 14.3. 
 (Z)-Ethyl 3-(allyloxy)-2-p-tolylacrylate (7b). Yellow oil. HRMS: 247.1358 [calcd. 
for C15H18O3 (M+H): 247.1363]. 1H NMR (300 MHz, CDCl3): δ 7.66 (s, 1H), 7.37-
7.22 (m, 4H), 5.95 (m, 1H), 5.4 (d, J = 18.8 Hz, 1H), 5.35 (d, J = 10.5 Hz, 1H), 4.53 
(d, J = 5.1 Hz, 2H), 4.30 (q, J = 7.1 Hz, 2H), 2.42 (s, 3H), 1.35 (t, J = 7.1 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ 167.7, 157.5, 136.5, 132.6, 129.7, 129.3, 127.7, 
118.6, 111.9, 74.9, 60.2, 21.2, 14.4. 
(Z)-Ethyl 3-(allyloxy)-2-(4-fluorophenyl) acrylate (7c). Yellow oil. HRMS: 
253.1237 [calcd. for C14H15FO3 (M+H): 251.1083]. 1H NMR (300 MHz, CDCl3): δ 
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7.63 (d, J = 4.0 Hz, 1H), 7.36 (m, 2H), 7.05 (m, 2H), 5.90 (m, 1H), 5.35 (d, J = 14.7 
Hz, 1H), 5.3 (d, J = 5.4 Hz, 1H), 4.53 (d, J = 5.4 Hz, 2H), 4.23 (q, J = 7.1 Hz, 2H ), 
1.30 (t, J = 7.1 Hz, 3H) . 13C NMR (75 MHz, CDCl3): δ  167.4, 163.3, 158.2, 132.3, 
131.8, 128.5, 118.9, 114.7, 111.0, 75.0, 60.3, 14.3. 
(Z)-Ethyl 3-(allyloxy)-2-(5-bromo-2-methoxyphenyl)acrylate (7d). Yellow oil. 
HRMS: 341.0120 [calcd. for C15H17BrO4 (M+H): 341.0388]. 1H NMR (300 MHz, 
CDCl3): δ 7.59 (s, 1H), 7.39–7.28 (m, 2H), 6.77 (d, J = 8.7 Hz), 5.93 (m, 1H), 5.32 
(d, J = 17.1 Hz, 1H), 5.28 (d, J = 9.6 Hz, 1H), 4.48 (d, J = 5.4 Hz, 2H), 4.20 (q, J = 
7.1 Hz, 2H), 3.76 (s, 3H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 
167.2, 157.8, 156.4, 134.2, 132.4, 131.4, 124.2, 118.6, 112.4, 112.1, 108.0, 74.8, 
60.1, 55.6, 14.3. 
(Z)-Ethyl 3-(allyloxy)-2-(4-chlorophenyl) acrylate (7e). Yellow oil. HRMS: 
267.0788 [calcd. for C14H15ClO3 (M+H): 267.0782]. 1H NMR (300 MHz, CDCl3): δ 
7.63 (s,1H), 7.50-7.25 (m, 4H), 5.90 (m, 1H), 5.34 (m,1H), 4.53 (d,1H), 4.23 (q, J 
= 7.1 Hz, 2H ), 1.30 (t, J = 7.1 Hz, 3H) . 13C NMR (75 MHz, CDCl3): δ 167.4, 158.5, 
132.3, 131.8, 128.5, 120.8, 118.9, 110.9, 75.0, 60.3, 14.3. 
 (Z)-Ethyl 2-(4-t-butylphenyl)-3-(allyloxy) acrylate (7f). Yellow oil. HRMS: 
289.1797 [calcd. for C18H24O3 (M+H): 289.1803]. 1H NMR (300 MHz, CDCl3): δ 
7.92 (s, 1H), 7.41–7.35 (m, 4H), 5.93 (m, 1H), 5.38 (d, J = 18.9 Hz, 1H), 5.32 (d, J 
= 10.8 Hz, 1H), 4.54 (d, J = 5.4 Hz, 2H), 4.26 (q, J = 7.1 Hz, 2H), 1.36 (s, 9H), 1.36 
(t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 167.8, 157.8, 149.5, 132.5, 129.5, 
128.3, 124.5, 118.7, 111.6, 74.9, 60.2, 34.4, 31.2, 14.3. 
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(Z)-ethyl 3-(allyloxy)-2-naphthalen-2-yl) acrylate (7g). Yellow solid. HRMS: 
283.1329 [calcd. for C18H18O3 (M+H): 283.1329]. 1H NMR (300 MHz, CDCl3): δ 
7.88-7.46 (m, 8H), 5.97 (m, 1H), 5.41 (m, 1H), 4.55 (d, J = 6.0 Hz, 2H), 4.28 (q, J 
= 7.1 Hz, 2H), 1.30 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 158.0, 133.1 
132.7, 132.4, 130.2, 129.3, 128.1, 127.6, 127.0, 125.8, 125.7, 118.9, 112.0, 75.0, 
60.4, 14.3. 
(Z)-Ethyl 3-(allyloxy)-2-(4-bromophenyl) acrylate (7h). Yellow oil. C14H15BrO3.  
1H NMR (300 MHz, CDCl3): δ 7.64-7.25 (m, 5H), 5.90 (m, 1H), 5.34 (m,1H), 4.53 
(d,1H), 4.23 (q, J = 7.1 Hz, 2H ), 1.30 (t, J = 7.1 Hz, 3H) . 13C NMR (75 MHz, 
CDCl3): δ 167.4, 158.5, 132.3, 131.8, 128.5, 120.8, 118.9, 110.9, 75.0, 60.3, 14.3. 
d. Synthesis of ethyl 2-formyl-2-arylpent-4-enoates (8) General procedure.  
In an oven dried and desiccator-cooled sealable test tube was added Pd2(dba)3 
CHCl3 (4.7-7.0 mg, 0.0045-0.00675 mmol, 0.025 equivalent) and (R,R)-L3 (8.5-
12.8 mg, 0.0108-0.0162 mmol, 0.06 equivalent). The test tube was then evacuated 
and backfilled with Ar three times. Previously degassed (50:1) Tol:MeOH (5 mL) 
was added to the flask and the mixture was stirred for 15 min until it was 
homogeneous and an orange color persisted. In the meantime, another test tube 
was charged with  (E)-ethyl-3-(allyloxy)-2-arylacrylate 7 (50.0 mg, 0.1844-0.2745 
mmol, 1.0 equivalent), evacuated and backfilled with Ar, and then degassed 
solvent Toluene:MeOH (5 mL: 100 µL) was introduced, unless otherwise 
mentioned and was stirred the mixture to dissolve. Both of the test tubes were then 
put into -200C cooling bath and stir for another 15 min before transferring the 
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substrate solution into the catalyst mixture via a cannula. The reaction was stirred 
for 72 h, unless otherwise mentioned. The reaction mixture was then passed 
through a thick pad of silica plug and the solvent was removed in vacuo. The pure 
product was isolated by column chromatography (5–10% ethyl acetate in Hexane) 
and identified by 1H NMR. 1H, 13C NMR and HRMS were applied to characterize 
the new compounds. 
H O
COOEt [Pd2(dba)3.CHCl3] (2.5 mol%)
     (R,R)-L3 (6 mol%)
Toluene: Methanol(50:1) 
         -20 oC, 72 h
O
COOEt
H
7 8
 
Scheme 52. Optimized reaction condition for the synthesis of compound 8. 
Ethyl 2-formyl-2-phenylpent-4-enoate (8a).  
Light yellow oil. HRMS: 233.1000 [calcd. for C14H16O3 
(M+H): 233.1177]. 1H NMR (300 MHz, CDCl3):  9.95 (s, 
1H), 7.44–7.23 (m, 5H), 5.76 (m, 1H), 5.13 (d, J = 18 Hz, 
1H), 5.07 (d, J = 9.9 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 3.14 (dd, J = 6.3, 13.8 Hz, 
1H), 2.88 (dd, J = 8.1, 13.8 Hz, 1H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, 
CDCl3):  196.3, 170.6, 135.0, 132.6, 129.0, 128.5, 127.8, 119.1, 65.6, 61.6, 37.5, 
14.0. 
O
O
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Chiral HPLC: 75% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 15.99 min (minor), 18.04 min 
(major). 
[α]D27: = + 73.50 (c = 0.082, EtOAc). 
Ethyl 2-formyl-2-p-tolylpent-4-enoate (8b).  
Yellow oil. HRMS: 247.1346 [calcd. for C15H18O3 (M+H): 
247.1334]. 1H NMR (300 MHz, CDCl3):  9.90 (s, 1H), 
7.28–7.12 (m, 4H), 5.75 (m, 1H), 5.15 (d, J = 18.3 Hz, 
1H), 5.08 (d, J = 10.5 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 3.12 (dd, J = 6.3, 13.8 Hz, 
1H), 2.88 (dd, J = 8.1, 13.8 Hz, 1H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (75MHz, 
CDCl3):  196.3, 170.8, 137.9, 132.8, 130.0, 129.0, 127.4, 118.9, 65.3, 61.5, 36.5, 
20.8, 14.0. 
Chiral HPLC: 75% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 14.00 min (minor), 15.35 min 
(major). 
[α]D27: = + 42.50 (c = 0.081, EtOAc). 
Ethyl 2-(4-fluorophenyl)-2-formylpent-4-enoate (8c).  
Yellow oil. HRMS: 251.1072 [calcd. for C14H15FO3 
(M+H): 251.1083]. 1H NMR (300MHz, CDCl3): δ 9.93 (s, 
1H), 7.28–7.07 (m, 4H), 5.73 (m, 1H), 5.20-5.05 (m, 2H), 
4.30 (q, J = 7.1 Hz, 2H), 3.11 (dd, J = 6.6, 14.1 Hz, 1H), 2.88 (dd, J = 7.8, 14.1 Hz, 
O
O
O
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1H), 1.30 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 196.0, 170.5, 160.5, 
132.3, 130.7, 129.2, 116.1, 115.8, 65.0, 61.8, 36.8, 14.0. 
Chiral HPLC: 70% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 16.00 min (minor), 17.48 min 
(major). 
[α]D27: = + 40.60 (c = 0.072, EtOAc). 
Ethyl 2-(5-bromo-2-methoxyphenyl)-2-formylpent-4-enoate (8d).  
Yellow oil. HRMS: 347.0244 [calcd. for C15H17BrO4 
(M+Li): 346.9698]. 1H NMR δ: 10.1 (s, 1H), 7.42-7.31 
(m, 2H), 6.75 (d, J = 8.7 Hz, 1H), 5.77 (m, 1H), 5.15-
5.05 (m, 2H), 4.20 (q, J = 7.1 Hz, 2H), 3.73 (s, 3H), 3.00 (dd, J = 6.6, 13.8 Hz, 1H), 
2.80 (dd, J = 7.8, 13.8 Hz, 1H), 1.26 (t, J = 7.1 Hz, 3H) . 13C NMR δ: 197.8, 170.6, 
155.5, 132.0, 130.8, 128.7, 128.0, 119.1, 113.4, 112.6, 68.0, 61.2, 55.7, 36.5, 14.0. 
Chiral HPLC: 90% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 13.57 min (minor), 15.99 min 
(major). 
Ethyl 2-(4-chlorophenyl)-2-formylpent-4-enoate (8e)  
yellow oil. HRMS: 267.0788 [calcd. for 
C14H15ClO3(M+H): 267.0782].1H NMR (300 MHz, 
CDCl3): δ 9.88 (s, 1H), 7.54 (d, j = 8.7, 2H), 7.13 (d, j 
= 8.7, 2H), 5.73 (m, 1H), 5.11 (m, 2H), 4.28 (q, J = 7.2 Hz, 2H), 3.10 (dd, J = 6.3, 
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13.8 Hz, 1H), 2.86 (dd, J = 7.8, 13.8 Hz, 1H), 1.29 (t, J = 7.1 Hz, 3H). 13C NMR (75 
MHz, CDCl3): δ 195.9, 170.3, 134.1, 132.2, 129.1, 128.7, 128.535, 128.4, 122.5, 
119.7, 65.2, 61.9, 36.7, 14.1. 
 Chiral HPLC: 73% ee, Regis Technologies Pirkle Covalent chiral stationary 
phase column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 13.89 min (minor), 
14.81 min (major). 
Ethyl 2-(4-tert-butylphenyl)-2-formylpent-4-enoate (8f).  
Yellow oil. HRMS: 289.1809 [calcd. for C18H24O3 
(M+H): 289.1804]. 1H NMR (300 MHz, CDCl3): δ 9.93 
(s, 1H), 7.42 (d, J = 6.7 Hz, 2H), 7.18 (d, J = 6.7 Hz, 
2H), 5.90 (m, 1H), 5.15 (d, J = 18.9 Hz, 1H), 5.10 (d, J 
= 12.3 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 3.15 (dd, J = 6.3, 14.1 Hz, 1H), 2.86 (dd, 
J = 8.1, 13.8 Hz, 1H), 1.33 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 196.2, 
170.8, 151.0, 132.8, 131.8, 126.8, 126.4, 119.3, 65.2, 61.5, 36.5, 34.4, 31.1, 14.0. 
Chiral HPLC: 79% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 11.59 min (minor), 12.33 min 
(major). 
[α]D27: = + 83.00 (c = 0.035, EtOAc). 
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Ethyl 2-formyl-2-(naphthalen-2-yl)pent-4-enoate (8g).  
yellow solid. HRMS: 283.1360 [calcd. for C18H19O3 
(M+H)+ : 283.1328] 1H NMR (300 MHz, CDCl3): δ 
10.02 (s, 1H), 7.91–7.34 (m, 7H), 5.82 (m, 1H), 5.19 
(d, J = 18 Hz, 1H), 5.13 (d, J = 9.9 Hz, 1H), 4.35 (q, J = 7.1 Hz, 2H), 3.25 (dd, J = 
6.3, 13.8 Hz, 1H), 3.01 (dd, J = 8.1, 13.8 Hz, 1H), 1.31 (t, J = 7.1 Hz, 3H). 13C NMR 
(75 MHz, CDCl3): δ 196.4, 170.8, 133.3, 132.7, 132.4, 128.9, 128.4, 128.2, 127.6, 
126.8, 126.7, 126.6, 124.7, 119.3, 65.8, 61.8, 36.8, 14.1. 
Chiral HPLC: 75% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 28.17 min (minor), 32.92 min 
(major). 
[α]D27: = + 48.50 (c = 0.067, EtOAc). 
HRMS (ESI): Calculated (m/z) for C18H19O3 (M+H)+ : 283.1328, Found 
283.1360.  
Ethyl 2-(4-bromophenyl)-2-formylpent-4-enoate (8h).   
Yellow oil. HRMS (M+H)+ : 311.0274 [calcd. for 
C14H16O3Br (M+H)+ : 311.0283].1H NMR (300 MHz, 
CDCl3): δ 9.88 (s, 1H), 7.54 (d, j = 8.7, 2H), 7.13 (d, j = 
8.7, 2H), 5.73 (m, 1H), 5.11 (m, 2H), 4.28 (q, J = 7.2 Hz, 2H), 3.10 (dd, J = 6.3, 
13.8 Hz, 1H), 2.86 (dd, J = 7.8, 13.8 Hz, 1H), 1.29 (t, J = 7.1 Hz, 3H). 13C NMR (75 
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MHz, CDCl3): δ 195.9, 170.3, 134.1, 132.2, 129.1, 128.7, 128.535, 128.4, 122.5, 
119.7, 65.2, 61.9, 36.7, 14.1.  
Chiral HPLC: 71% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 14.57 min (minor), 15.57 min 
(major). 
[α]D27: = + 78.30 (c = 0.058, EtOAc). 
HRMS (ESI): Calculated (m/z) for C14H16O3Br (M+H)+ : 311.0283, Found 
311.0274. 
3.2. Synthesis of (Z)-ethyl 3-((E)-but-2-en-1-yloxy)-2-phenylacrylate (14): 
General procedure:  
Ethyl 2-aryl-3-hydroxyacrylate 3 (1.0–5.0 mmol) was dissolved in freshly distilled 
dichloromethane (5–10 mL) under nitrogen. Bu4NI (0.1 equiv.), crotyl bromide (1.2 
equiv.), and potassium hydroxide (10 equiv.) were added, and the reaction mixture 
was stirred at room temperature until reaction completion was confirmed by NMR. 
The reaction was quenched by adding saturated NH4Cl, and the aqueous layer 
was extracted with diethyl ether (2 × 25 mL). The organic extracts were combined 
and dried over Na2SO4. The organic layer was then passed through a silica plug 
and the solvent was removed by rotary evaporation. Pure product was isolated by 
column chromatography (5–10% ethyl acetate in pentane) and identified by 1H 
NMR. 1H, 13C NMR and HRMS were applied to characterize the new compounds. 
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(Z)-ethyl 3-((E)-but-2-en-1-yloxy)-2-phenylacrylate (14):  
Yellow oil. HRMS: 247.1334 [calcd. for C15H18O3 (M+H): 
247.1329]. 1H NMR (300 MHz, CDCl3): δ 7.66 (s, 1H), 
7.45-7.30 (m, 5H), 5.85 (m, 1H), 5.63 (m, 1H), 4.47(d, J = 
4.0 Hz, 2H), 4.26 (q, J = 7.1 Hz, 2H), 1.77(d, J= 6Hz, 3H), 1.30 (t, J = 7.1 Hz, 3H). 
13C NMR (75 MHz, CDCl3):δ 167.9, 157.8, 132.7, 132.4, 130.2, 127.6, 126.9, 
124.7, 111.7, 75.1, 60.2, 17.8, 14.3. HRMS (ESI): Calculated (m/z) for C15H18O3 
(M+H)+ : 247.1329, Found 247.1334. 
General procedure for the synthesis of compound 15 and 16: 
In an oven dried and desiccator-cooled sealable test tube was added Pd(PPh3)4 
(5.0 mg, 0.0045-0.01mmol, 0.050 equivalent) at room temperature under argon. 
Previously degassed dichloromethane (3 mL) was added to the flask and the 
mixture was stirred for 15 min until it was homogeneous and a golden yellow color 
persisted. (Z)-Ethyl 3-((E)-but-2-en-1-yloxy)-2-phenylacrylate 14 (50.0 mg, 0.203 
mmol, 1.0 equivalent) was then added via syringe.  The reaction was stirred for 
overnight, unless otherwise mentioned. The reaction mixture was then passed 
through a thick pad of silica plug and the solvent was removed in vacuo. The pure 
product 15 and deformylated product 16 was isolated by column chromatography 
(5–10% ethyl acetate in Hexane) and identified by 1H NMR. 1H, 13C NMR and 
HRMS were applied to characterize the new compounds. 
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Scheme 53. Synthesis of compound 15 and 16 from o-crotylated substrate 14.  
(E)-ethyl 2-formyl-3-methyl-2-phenylpent-3-enoate (15):   
Yellow oil. HRMS: 247.1334 [calcd. for C15H18O3 (M+H): 
247.1329]. 1H NMR (300 MHz, CDCl3): δ 9.87 (s, 1H), 7.40-
7.21 (m, 5H), 5.90 (m, 1H), 5.1 (m, 1H), 4.98(m, 2H), 4.36 (q, 
J = 7.1 Hz, 2H), 3.46 (m, 1H), 1.33(t, 3H), 1.1 (t, 3H). 13C NMR (75 MHz, CDCl3):δ 
196.2, 170.3, 139.1, 134.2, 128.8, 128.6, 127.9, 116.3, 69.4,61.6, 41.2, 16.5, 14.1. 
HRMS (ESI): Calculated (m/z) for C15H18O3 (M+H)+ : 247.1329, Found 247.1334. 
 (E)-ethyl 2-phenylhex-4-enoate (16):  
Yellow oil. HRMS: 219.1385 [calcd. for C14H18O2 (M+H): 
219.1380] 1H NMR (300 MHz, CDCl3): δ 7.35-7.30 (m, 
5H), 5.50 (m, 1H), 5.34 (m, 1H), 4.14 (m, 2H), 3.60 (m, 
1H), 2.78 (m, 1H), 2.45(m, 1H), 1.63(d, 3H), 1.24 (t, 3H). 13C NMR (75 MHz, 
CDCl3): δ 173.6, 138.9, 128.5, 127.9, 127.8, 127.6, 127.1, 60.6, 52.1, 36.7, 17.9, 
14.2. 
HRMS (ESI): Calculated (m/z) for C14H18O2 (M+H)+ : 215.1380, Found 215.1385. 
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 II. SYNTHESIS OF CHIRAL TRYPTOPHAN ANALOGS AND 
STUDIES TOWARDS SYNTHESIS OF TRYPROSTATIN A AND B. 
CHAPTER 4. SYNTHESIS OF ASYMMETRIC TRYPTOPHAN  
4.1.1. Introduction 
Optically active tryptophans have been regarded as important components in the 
areas of both synthetic and medicinal chemistry.49 Ring-A substituted tryptophans 
have been utilized in the design and synthesis of many biologically active 
compounds, including indole-based alkaloids, which have recently been receiving 
attention for their anti-cancer properties.50 Several methods are known to 
effectively synthesize enantiopure tryptophans, but most strategies are only 
suitable for a particular species of tryptophan. 51 Many of these methods use 
stoichiometric amounts of chiral auxiliaries and extensive multistep syntheses, and 
often involve problematic separation of isomers obtained in the alkylation and 
annulation steps.51 In recent years, asymmetric phase-transfer catalysis (PTC) has 
been established as a powerful tool in the synthesis of chiral mono- and di-
substituted α-amino acids.52, 53 To date, the only reported asymmetric substitution 
of this type utilizes a relatively unstable Boc-protected indole to synthesize α-
methyl tryptophan in 78% yield and 91% ee,53e but there has not been a general 
synthesis of chiral tryptophans via PTC reported. In this paper, we describe a 
simple, cost-effective, one-pot synthetic procedure that can be used to prepare 
chiral tryptophan derivatives via a phase-transfer-catalyzed (PTC) asymmetric 
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alkylation reaction. We believe that this approach is the most economical and 
versatile process for synthesizing these important chiral building blocks. 
4.1.2. Indole and Tryptophan  chemistry 
In our group we have a procedure 54 for the synthesis of substituted indole ethyl 
ester 19, starting from substituted o-nitro aldehyde 17 in two steps. In the first step 
Bronsted acid catalyzed formation of hydoxyarylacrylate 18 , which after 
hydrogenation fromed indole compound 19 in good yield (Scheme 54 ). 
CHO
NO2R
HBF4⋅OEt2(10 mol%) 
N2CHCO2Et (1.2 eq.)
CH2Cl2,    
O or -78 °C
NO2R
COOEt
OH
H
Pd/C, H2
MeOH N
H
R
COOEt
17 18 19
R=H, 5-MeO, 
4,5-MeO,
4-OCH2O-5, 
5-Cl
50-86% yield 62-90% yield
 
Scheme 54. Synthesis of indole-3-ethyl ester 19, from substituted o-
nitrobenzaldehyde. 
A series of indole-based indole-3-carboxamides could be efficiently synthesized 55 
from various indole-3-carboxylates using an amidoaluminum-mediated strategy 
(Scheme 55). The treatment of ethyl indole-3-carboxylates bearing a range of 
substitution patterns on the indole ring with various amidoaluminum complexes, 
led to the corresponding 1H-indole-3-carboxamides in yields up to 75%. Reduction 
by diisobutylaluminum hydride afforded the corresponding gramines in 63-85% 
yield. This is the first reported example of amidoaluminum complexes of type 
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Al2(CH3)4(NR2)2 promoting facile amidation of relatively inert indole esters. 
1) PhMe, 100 °C
2) H2O
N
CO2Et
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AlMe2(NMe2)2
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O
N(Me)2
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2) H3O
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21 22
indole-3-carboxamide
20
R1 Yield 21 Yield 22
H 77 94
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Scheme 55. Synthesis of gramine analogs from indole ethyl ester. 
Since first report by Snyder 56, gramine and its methiodide salts has been used for 
the synthesis of tryptophan. The quaternary ammonium salt was condensed with 
compounds having active methylene groups such as acetylaminomalonic ester to 
give aminodiester compound. After subsequent hydrolysis racemic tryptophan was 
synthesized in moderate yield (Scheme 56). 
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Scheme 56. Synthesis of racemic tryptophan from gramine. 
In 2007 Cook group reported 51e the synthesis of 4-methoxytryptophan in good 
yield and optical purity. Before that it was made via a kinetic resolution of 
tryptophan produced by the use of immobilized penicillin G acylase reported by 
Ley et al. In previous studes they found that the Larock heteroannulation 
concomitant with Schollkopf chiral auxiliary is a powerful method for the synthesis 
of ring-A substituted indole derivatives and has been utilized for the regiospecific 
synthesis of both 11- and 12-methoxy-substituted indole alkaloids. Hydrolysis of 
the Schollkopf chiral auxiliary along with the loss indole 2-silyl group provided with 
a high yielding synthesis of 4-methoxy tryptophan (Scheme 57).  Better selectivity 
was achieved when a bulky silyl-substituted internal alkyne is used as a substrate 
also from the steric interactions between the ortho substituent and the substituent 
on the alkyne.  
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Scheme 57. Synthesis of chiral 4-methoxytryptophan using Larock hetero 
annulations and chiral Schollkopf auxiliary. 
 
Reisman group in 2012 reported 57 the tandem Friedel−Crafts conjugate addition/ 
asymmetric protonation reaction between 2-substituted indoles and methyl 2-
acetamidoacrylate. The reaction is catalyzed by (R)-3,3′-dibromo-BINOL in the 
presence of stoichiometric amount of SnCl4.  BINOL·SnCl4 complex  acts as a 
catalyst for this  tandem conjugate addition /asymmetric  protonation reaction. 
They have reported a range of indoles furnished synthetic tryptophan derivatives 
in good yields and high levels of enantioselectivity (Scheme 58). 
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Scheme 58. Enantioselective Synthesis of Tryptophan Derivatives by a 
TandemFriedel−Crafts Conjugate Addition/Asymmetric Protonation Reaction. 
 
4.1.3.  Phase transfer catalysis: general concepts and mechanisms of 
action  
In 1946, the first example of a phase transfer catalyzed reaction was reported on 
the alkylation reaction of a sodium carboxylate salt. During the reaction the phase 
transfer catalyst, benzyltriethylammonium chloride is formed in situ by the attack 
of trimethylamine base to benzyl chloride (Scheme 59).58 
 
 
Scheme 59. First report of phase transfer catalysis . 
Starks established the fact that there is a significant increase in the reaction rate 
for the tetralkyammonium or tetralkylphosphonium catalyzed reaction between an 
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aqueous solution of sodium cyanide and organic solution of an alkyl halide 
(Scheme 60). It was in 1971 that Starks for the first time reported the term ‘phase 
transfer catalysis’59. 
 
 
Scheme 60. Phase transfer catalyzed reactions reported by Starks. 
 
 
Figure 14. Mechanism for halide displacement by cyanide ion catalyzed by PTC. 
 
Because of the insolubility of NaCN in the organic phase the reaction is incapable 
to proceed without the help of a PTC. Therefore, electrophile and nucleophile are 
unable to meet and react. By using ion exchange at the interface of organic and 
aqueous phase PTC “shuttle” the cyanide ion into the organic phase. From the 
interface, the new ion pair (Q+CN-) then travels to the organic phase where it is 
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permitted to readily react with the electrophile (Figure 14). This mechanism is 
known as the extraction mechanism, when the organic phase reaction is rate 
determining step, like the reaction between cyanide and octyl bromide in the above 
example. On the other hand, when the transfer of the ion from aqueous solution to 
the organic phase (the transfer step) is rate determining step, the mechanism is 
known as the interfacial mechanism.  
Factors affecting the rate at which the transfer of ions into the organic phase takes 
place include: 
a) Interfacial tension: An increase in the interfacial tension resulted from the decrease 
of the interfacial area, which resulted in lowering the transfer rate from the aqueous 
into the organic phases. Due to an increased interfacial tension, highly 
concentrated solutions and non-polar solvents result in a decrease of the interfacial 
area. 
b) Stirring: Formation of tiny droplets present in emulsions can greatly increase the 
interfacial area leading to enhanced reaction rates. High stirring speeds can help 
to form these tiny droplets thereby generate larger surface area.. 
c) The cation bulkiness of PTC: Typically, unsymmetrical cations allow closer 
approach of the cation to the interface, boosting the transfer step. Bulkier alkyl 
groups lower the rate in the transfer step by a decrease of the effective 
concentration of the cations at the interface. 
d) Nature of the anion in the PTC: Larger anions that are weakly hydrated for example 
iodide and perchlorate allow easier access to the interface from the organic phase. 
The reverse is true for small anions such as hydroxide or fluoride that are hydrated 
with much greater ease. 
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Phase transfer catalyzed reaction are affected by the following variables: 
 
a) Catalyst:  There are some factors such as catalysts ability to promote the 
transfer of the substrate anion into the organic phase, the surfactant property 
of the catalyst, transfer rates depends on the shape and size of the catalyst. 
Moreover, in the activation of the anion for reaction towards reactant in the 
organic phase, the catalyst may perhaps be a major factor. Under the 
commonly used basic conditions, many phase transfer catalysts are capable 
to go through a Hoffmann elimination. For that reason a catalyst should be 
selected that will be practically stable under the strong basic conditions 
employed. 
b) Concentration: Concentration plays an important role in phase transfer 
catalysis. The use of more concentrated solutions leads to an increased 
interfacial tension and a decreased transfer rate. The transfer of anions into 
the organic phase will be promoted by using more concentrated solutions, 
provided that this is not the limiting factor, thereby promoting formation of the 
catalyst substrate complex.  
 
c) Solvent: Choice of solvent plays important role because it can affect both the 
rate of the reaction taking place in the organic solvent and the interfacial 
tension, which can affect the transfer rate. Commonly dichloromethane is used 
as a solvent because of its capacity to readily dissolve most phase transfer 
catalysts. 
d) Temperature: Generally, in the presence of base and at high temperature 
phase transfer catalyst decomposes, therefore a temperature should be 
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selected for optimal rate of reaction while circumventing decomposition of the 
catalyst. 
 
The use of phase transfer catalysis also presents severak practical advantages: 
1) Expensive and stronger, moisture sensitive organic soluble bases such as 
MHMDS bases (M= Li, Na, K etc.), NaH, t-BuOK etc can be replaceded by 
inexpensive inorganic bases e.g., K2CO3, NaOH, KOH. The work-up process is 
also simplified and reaction can be done in ambient condition it does not require 
special conditions such as an inert atmosphere. 
2) There are many reactions that have been reported with High % yields, 
enantioselectivity and purity. 
3) The reactions are generally cost effective and be likely to decrease 
industrial waste. 
4) The reactions are low maintenance and have the potential for scale-up, which is 
advantageous for industrial processes. 
There are many different reactions that have been successfully accomplished 
using phase transfer catalysis. To mention just a few of the reactions that have 
found application in asymmetric catalysis via phase transfer catalysis include: 
alkylations, Michael additions, aldol reactions, cyclopropanations, epoxidations, 
Darzens reactions, oxidations  and aziridinations.60 To illustrate the mechanism of 
the asymmetric phase transfer catalyzed reaction,the asymmetric alkylation of t-
butyl glycinate esters is described (Figure 25). 
 
92 
 
 
 
 
Figure 15. Mechanism for phase transfer catalyzed alkylation of Schiff bases. 
 
Active methylene or methine hydrogens alkylation happens via the interfacial 
mechanism. Specifically, the exchange of ions taking place at the interface 
between the conjugate base of the substrate and the quaternary ammonium salt 
is the rate determining step (RDS). Therefore organic soluble enolate comes in 
contact with a quaternary ammonium ion as the counter ion. At the interface, when 
the glycinate Schiff base comes in contact with water soluble base, the glycinate 
becomes deprotonated, resulting the related enolate ion (Figure 25). At this point 
it is critical for the phase transfer catalyst to quickly exchange ions with the enolate, 
or else the enolate will directly react with the electrophile at the interface, forming 
racemic product. At the interface, after the ion exchanges between enolate and the 
PTC, it become organic soluble and goes into the organic phase, where it will react 
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with the electrophile in an asymmetric fashion with the help of the close-fitting ion 
pair formed between the chiral quaternary ammonium ion and prochiral enolate. 
 
 
4.2. Results and discussion 
4.2.1 Procedure for the synthesis of Tryptophan 
In this study, a cinchona-derived phase-transfer catalyst was employed in the first 
reported PTC synthesis of chiral tryptophans, with varying substitution patterns, 
using a protected glycine Schiff base and various gramine derivatives. The first 
experiment, using substrate, glycine Schiff base , catalyst , and 50% aqueous 
NaOH/CH2Cl2 resulted in a disappointing racemic mixture of product with a 
chemical yield of 15% and reaction time of 50 h ( Scheme 61). Such alkylation 
using gramine has been thoroughly studied in achiral systems with an intermediate 
3-methylene- indolenine (Scheme 61) being identified.[6] Low chemical yield was 
attributed to the arduous task of eliminating (CH3)2NH to generate the product. To 
offset this matter, gramine was converted to a quaternary salt using CH3I, which 
resulted in a much improved chemical yield of 75% ( Scheme 62), albeit no 
asymmetric induction. This may be due to the fact that gramine salt is very soluble 
in water, and very insoluble in dichloromethane, which is not an ideal condition for 
an asymmetric PTC reaction. 
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Scheme 61. Reaction of gramine 23  with glycinate Schiff base  26 in the presence 
of the phase transfer catalyst 27 and an external base. 
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4.2. 2. Optimization study for the synthesis of chiral Tryptophan 
analogs. 
N
R1
CH3I
N
R1 N
R1
NC(Ph)2
O
Ot-Bu
23 R1=H, 
29 R1=TIPS,
C6H6, 24h, rt
28 R1=H, 
30 R1=TIPS,
NaOH/H2O  (20eq)
Schiff base, 
PTC(1 eq)
CH2Cl2, rt
24 R1=H,  75%, 0% ee
31 R1=TIPS, 63%, 84% ee
NMe2 N(Me)3
I
 
Scheme 62. Synthesis of quaternary salt  by reaction of gramine  with CH3I, 
followed by alkylation with glycinate  under phase-transfer conditions using phase 
transfer catalyst  and external base. 
In order to improve the asymmetric induction, we attempted to change the polarity 
of the quaternary salt, so it became very soluble in dichloromethane and partially 
soluble in water. By introducing a bulky hydrophobic triisopropylsilyl (TIPS) 
protecting group on the indolylic nitrogen of the substrate ( Scheme 62), we 
managed to improve the optical yield (84 %ee) of the PTC alkylation reaction using 
1 eq of catalyst ( Scheme 62). In addition, the TIPS group was removed during the 
alkylation process. We screened some other commercially available catalysts to 
determine if there are any other catalysts that would be more effective than O-Allyl-
N-(9-anthracenylmethyl)-cinchonidinium bromide catalyst (scheme 61)  for this 
alkylation reaction. From our results as summarized in Scheme 63 it was revealed 
that  9-anthracenyl catalyst was the catalyst of choice for best optical yields. 
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Scheme 63. Results from some commercially available phase-transfer catalysts 
in the alkylation reaction. 
Further studies revealed that changing the quaternization reagent from CH3I to 4-
(trifluoromethoxy) benzyl bromide (Scheme 63) eliminated the protection/de-
protection steps, allowing for the quaternization and chiral alkylation steps to be 
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carried out in one-pot (Scheme 64). The one-pot asymmetric alkylation was a 
success due to fact that the salt formed from 4-(trifluoromethoxy) benzyl bromide 
and gramine was found to be insoluble in water. Changing quaternization reagents 
from CH3I to 4-(trifluoromethoxy) benzyl bromide ( Scheme 64), not only rendered 
a one-pot transformation feasible, but also resulted in both an increase in overall 
percent yield and a shorter reaction time (<1h) (Figure 16). The 1H NMR studies 
showed no evidence of indolenine formation in the one-pot process using 4-
(trifluoromethoxy) benzyl bromide  at 25 °C, which suggests that alkylation might 
be occurring via nucleophilic substitution rather than elimination-addition. This was 
further supported by methylating the indolylic nitrogen  and observing minimal loss 
in yield and induction (Scheme 64).  
 
Figure 16. Screening of quaternization reagents using gramine under ambient 
conditions 
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Scheme 64. One-pot synthesis of chiral tryptophanate  by reaction of gramines 
with glycinate and 9-anthracenyl chinchonindin catalyst respectively using 
quaternization reagent 7 under ambient conditions. 
 
In order to further improve the chemical and optical yields some variables were 
studied for the alkylation reaction in dichloromethane. Increasing the concentration 
of aqueous NaOH from 10% to 50% resulted in increase of optical yield. Changing 
base from 50% aqueous NaOH to 45% aqueous KOH resulted an increase in 
optical yield from 65% ee to 80% ee. Other common bases such as CsOH and 
Ba(OH)2 did not improve the chemical or optical yields of the product. Further 
screening of solvents like THF (6% ee), dioxane (84% ee) and toluene (71% ee) 
showed that similar results were obtained with CH2Cl2 and dioxane, leading to 
slightly higher enantioselectivity. Lowering the reaction temperature from 25 °C to 
–30 °C resulted in a further increase in optical yield; temp (% ee, time): 25 °C (80%, 
2h), -30 °C (84%, 8h). However, further cooling (-78 °C) increase the reaction time 
to 15h but gave no additional improvement in optical yield. The low temperature 
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reactions were run in dichloromethane as the dioxane freezes at subzero 
temperature. Although we had determined that increased reaction rates and 
selectivity is achieved with higher base concentrations, the effect of water on 
enantioselectivity was also studied (Table 9). We discovered that a minimum of 6 
equivalents of water is needed to achieve an excellent optical yield of the product 
(entry 2, Table 9). In these reactions, a minimum 20 mol% of catalyst is required 
for best chemical and optical yields.  
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Table 9. Effects of base and substrate concentration on asymmetric PTC of 
gramine. 
1) 4-(CF3O)BnBr (1 equiv), 25 °C, 0.5 h
2) base (20 eq), glycinate(1 equiv)
cat (20 mol%), CH2Cl2, 25 °C
N
H
NMe2
N
H
NC(Ph)2
Ot-Bu
O
23 24  
Run Conc(gramin
e)[c] 
Base 
(% aq) 
Time (h) % Yield[d] % ee[e] 
1 0.10 10% NaOH > 24 18 50 
2 0.10 50% NaOH 8 47 75 
3[b] 0.01 50% NaOH 16 42 71 
4 0.10 10% KOH 5 65 65 
5 0.10 45% KOH 2 >95 84 
6 0.10 10% KOH 2 97 80 
7 0.10 10% CsOH 3 18 59 
8 0.10 10% Ba(OH)2 13 16 46 
9 0.10 25% K2CO3 N.R.[f] 0 0 
[a] 0.10 M gramine in CH2Cl2/aq base (20 equiv), 25 °C. [b] 0.01 M gramine in 
CH2Cl2. [c] Molar. [d] Yield determined by HPLC. [e] Determined by chiral HPLC 
using: Chiralcel-OD column, 5% IPA in heptane, 254 nm DAD, 1 mL/min flow rate, 
40 °C column temperature. [f] No reaction. 
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Table 10. Results of PTC reaction in varying amount of water. 
N
H
NMe2
2) glycinate (1eq), 
cat (20mol%)
solid KOH (20eq), -30°C
1)  benzyl bromide (1eq), 
CH2Cl2, 25°C, 30min
N
H
NC(Ph)2
Ot-Bu
O
23 24  
 
Entry Water (eq) Time (h) % Yield[a] % ee[b] 
1 100 8 80 85 
2 6 18 80 92 
3 3 19 >95 83 
[a] Yield determined by HPLC. [b] Determined by chiral HPLC using: Chiralcel-OD 
column, 5% IPA in heptane, 254 nm DAD, 1 mL/min flow rate, 40 °C column 
temperature. 
Once the alkylation variables were optimized, we began structure-activity-
relationship studies of catalyst  (Scheme 64) in the asymmetric one-pot alkylation 
of gramine and glycinate schiff’s base in CH2Cl2 at –30°C using solid KOH with 6 
eq of water. The study revealed that both the bromide counter-anion and the N-
anthracenyl group play an intimate role in the ability of catalyst to induce high 
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optical yield. Changing the counter-anion from bromide to chloride resulted in a 
decrease in optical yield to 60% (Scheme 64), which may be due to increased 
solubility of the catalyst in water. Substituting the anthracenyl group with a less 
bulky 3,4,5-trifluorobenzyl group also resulted in a decrease in optical yield to 70% 
(Scheme 65). Steric influences were believed to be the contributing factor toward 
increasing enantiodifferentiation. 
N
O N
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H2C
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N
O N
H2C
Br
H2C
N-benzyl group effect
(ee% < 60%) (ee% < 70%)
N
H
NMe2
2) (R,R)-cat (0.2eq), KOH (20eq)
     H2O (6eq), -30°C, 18 h
NPh
Ph
CO2t-Bu
1eq
1) 4-(CF3O)BnBr, 25°C
30 min, CH2Cl2
N
H
NC(Ph)2
Ot-Bu
O
F
F
F
Gramine Tryptophan derivative
23 24
27
38
 
 Scheme 65. Structure-activity-relationship (SAR) studies in the asymmetric 
alkylation of gramine with glycinate with external base in a one-pot reaction. 
 
4.3. Scope of chiral phase transfer catalyzed reaction for the synthesis 
of Tryptophan analogs. 
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After optimizing our reaction with gramine, which resulted in a good yield and 
excellent %ee, we expanded the scope of our study to other gramine-type 
substrates, specifically ring-A substituted gramines such as 5-methoxy, 6-
methoxy, and 5-bromogramine (Scheme 66).  All the gramines tested are 
commercially available and provided good yields with excellent optical purity. In 
conclusion, a systematic study of substrate, catalyst, reagents, and reaction 
conditions has led to a simple, enantioselective synthesis of L-tryptophan 
derivatives using chiral phase-transfer catalysis in a three-component/one-pot 
fashion 61. The configuration of compounds was determined by converting them to 
the known L-tryptophans and by measuring their optical rotations. 
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Scheme 66. Optimal asymmetric alkylation conditions of various gramines. 
CHAPTER  5.  APPLICATION OF TRYPTOPHAN CHEMISTRY 
TOWARDS THE TOTAL SYNTHESIS OF TRYPROSTATINS. 
5.1. Synthesis of Tryprostatins 
Tryprostatins are diketopiperazine, tryprostatin A reverses the resistance of cancer 
cells against antitumor drugs  by arresting cell cycle progression at the G2/M phase 
and also known to inhibits the ABC-transporter breast cancer resistance protein. 
Early synthesis of Tryprostatin was done by Danishefsky’s group in 1996 using the 
following scheme 61. This goal was achieved by cleavage of the N-phthaloyl group 
42, followed by coupling of the resultant amino ester with N-Boc-L-proline acid 
fluoride to afford first amide linkage 44. Deprotection of Boc-group led to the next 
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intermediate 45 and then, by diketopiperazine formation, to Tryprostatin B 
46(Scheme 67).  
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3:1 MeOH/CH2Cl2 (0.1)M 
24 hr 82% yield
N
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O
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N
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O
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NH3/MeOH 
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67% yield
N
H
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N
O
O
H
H
Tryprostatin B
42 43
44 45
46  
Scheme 67. Total synthesis of Tryprostatin B starting from chiral tryptophan. 
Professor Cook’s group synthesized Tryprostatins in 2002 and 2008 using slightly 
different procedures 62.  They achieved this using the reaction scheme shown 
below (Scheme 68). The synthesis began with indoles 47,  which were then 
coupled with the anion of the Scho¨llkopf chiral auxiliary, to afford the trans 
diastereomer 49  with 100% diastereoselectivity. The 2-isoprenylpyrazine 
derivatives of Indoles 50 were obtained by treating with LDA at  -78 oC, followed 
by addition of isoprenyl bromide. The pyrazine group was removed  under acidic 
conditions  in 94% yield to afford the 2-isoprenyl tryptophan 51. The coupling of 2-
isoprenyl tryptophan with Fmoc -D-proline using triethylamine as the base was 
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followed by formation of the diketopiperazine ring. The Boc protecting group was 
removed from the indole N(H) function in refluxing xylene to afford Tryprostatin A 
and B 46. 
N
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N
Boc
CH2Br
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N
N
OEt
OEt
THF 
n-BuLi
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N
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R N
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Scheme 68. Total synthesis of Tryprostatin A and B starting from 3-methyl indoles. 
In Professor Cook’s synthesis the Schöllkopf Chiral Auxiliary 52 is made from 
triphosgene  and L-valine (Scheme 69). 
H2N
OH
O triphosgene
(0.35eq)
HN
OO
O Glycine
HN
NH
O
O
Fresh
Et3O
+BF4
-,
N
N
EtO
OEt
O O
O
Cl
Cl
Cl
Cl
Cl
Cl
CHCl3, Et3N
THF, 0°C CH2Cl2, rt
THF, 40-45°C
52  
Scheme 69. Synthesis of  Schöllkopf chiral auxiliary. 
In the synthesis they also have to Boc protected skatole 47 shown below which is 
not reported as a step in the synthesis (Scheme 70).  There are very few 
substituted skatoles commercially available to make derivatives with. 
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Scheme 70. Boc protection of indole amino group. 
One of the more current syntheses 63 from 2010 is shown in the synthetic scheme 
shown below (Scheme 71).  This synthesis has 11 steps a 30% yield and utilizes 
a toxic tin coupling reagent and triphosgene.  In this radical-mediated cyclization  
they focused on the synthesis of the isocyanide compound as a radical-cyclization 
precursor.  After the Sonogashira coupling between terminal alkyne and 2-
iodoformanilide 54 the resultant compound was selectively reduced to cis alkene 
56. Subsequent dehydration with triphosgene afforded the ortho-alkenyl 
isocyanide 57 and thus ready for a radical-mediated cyclization. Isocyanide 
compound was then subjected to established radical-cyclization conditions to give 
the 2-stannylindole followed by Pd mediated isoprenyl coupling at C-2 position to 
get compound 58. It  was then transformed into the corresponding amino acid  in 
a three-step sequence consisting of protection of the indole with a Boc group, 
hydrolysis of the acetonide, and oxidation of the resulting alcohol  to the carboxylic 
acid  withTEMPO. After condensation with l-proline methyl ester, the removal of 
the two Boc groups and cyclization completed the construction of diketopiperazine 
61. 
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Scheme 71. Total synthesis of Tryprostatin A from 2-iodo,5-methoxy aniline. 
5.2. RESULTS AND DISCUSSIONS 
In our attempt to synthesize tryprostatins, Huisman  proceeded with our proposed 
scheme which is complementary to the Cook group synthesis (Scheme 72).   After 
synthesis of asymmetric tryptophan 24 via phase transfer catalyzed reaction Indole 
will be protected with Boc-group 62. The compound will then undergo a C-2 
alkylation reaction to get compound 63 with isoprenyl bromide in presence of LDA 
at -78 oC. Subsequent hydrolysis and coupling of Fmoc-proline will afford 
tryprostatin B 46 (Scheme 72). 
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Scheme 72. Proposed total synthesis of Tryprostatins. 
This procedure was working well up until the synthesis of Boc-protected tryptophan 
62.  C-2 alkylation of 62 seems to be a problematic reaction in chiral tryptophan, 
after alkylation reaction Huisman isolated compound 65 that had the isoprenylation 
on the amino acids α-carbon. Alkylation happen at the most acidic proton at chiral 
center instead of C-2 position of indole structure for compound 63 (Scheme 73).  
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Scheme 73. Synthesis of indole C2-isoprenylated tryptophan. 
The problem was circumvented by making quaternary gramine salt 67 necessary 
for the PTC reaction and  C2-alkylation at the same step using 2.5 equivalent of 
isoprenyl bromide (Scheme 74). Then we proceeded with our proposed scheme.  
N
N
OO
N
N
OO
Br
n-BuLi
Br
-70°Cto rt, THF
Boc-gramine
Boc-protected 
Indole 2-isoprenyl salt
67
66
 
Scheme 74. Procedure for quaternary di-isoprenyl bromide salt 67 of gramine. 
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The next step is phase transfer catalyzed tryptophan synthesis, and we found that 
C-2 alkylation of gramine quaternary ammonium salt 67 is a totally different 
substrate than unsubstituted  regular tryptophan. Our established procedure for 
chirality induction via PTC reaction is ineffective for this new substrate, after 
optimization Huisman reported only 42% ee in 1,4-Dioxane solvent at room 
temperature (Scheme 75). 
N
N
Boc
n-BuLi 2.0 eq
Br CH3
CH32.5 eq
N
N
Boc NH
N
Ph
Ph
O
O
Glycinate 45% KOH
R,R cat 0.2eq
1,4 Dioxane, rt 
95% yield
12 hr 42%ee
THF, -78 °C
80% yield
12 hr
66 67 68
 
Scheme 75. Preparation of tryptophan using gramine  isoprenyl salt. 
At this point of synthesis we avoided the alkylation at chiral center 65, but we are 
in need of a protocol to improve the enantioselectivity of phase transfer catalyzed 
reaction of C-2 alkylated substrate 67. In order to optimize the reaction for new 
substrate we again screened phase transfer catalysts (Figure 17) with our 
established protocol. Alkylation at C-2 position with bulky isoprenyl group might 
interfere with the chiral catalyst, so we tried different catalyst which is more open 
in their ammonium core such as catalyst 32. We found that catalyst 32  is 
moderately effective to induce higher enantioselectivity (50% ee) for the phase 
transfer catalysis reactions( Table 11, entry 4). 
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Figure 17 . Chiral phase transfer catalysts. 
Table 11. Catalyst screening for the synthesis of 68. 
N
N
OO
Br
O
N
O
N
H
N
O
O
PTC (20 mol%)
Base
Solvent
6867
 
Entry Catalyst Solvent Base %ee 
1. 27 1,4-Dioxane CsOH 39 
2. 34 1,4-Dioxane CsOH 39 
3. 33 1,4-Dioxane CsOH racemic 
4. 32 1,4-Dioxane CsOH 50% 
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5. 27 Tol:Dioxane(1:1) CsOH 65% 
6. 27 Tol:CHCl3(4:1) CsOH 49% 
 
Among the chiral catalysts screened for the transformation of 67, we found catalyst 
27 is the most effective one (Table 11, entry 5) which has previously been used 
for the synthesis of unsubstituted chiral protected tryptophan (Scheme 76). 
N
N
OO
Br
O
N
O
N
H
N
O
O
PTC (20 mol%)
45% KOH
Acetonitrile
N
O N
H2C
Br
H2C
27
6867
Scheme 76. Synthesis of 2-isoprenyl-N-diphenylmethylene-t-butyl ester 
tryptophan 68. 
 For further optimization we then screened different solvent system, base, and 
concentration of reactions using catalyst 27. Solvent polarity plays an important 
role in dissolving phase transfer catalyst and in maintaining the concentration of 
catalyst in organic phase and above all in the transfer process. Polar solvent can 
dissolve catalysts easily, but were found to be ineffective to induce chirality to the 
product ( Table 12, entry 5,8,9). Toluene and Dioxane were observed to be the 
most promising solvent for optimal catalyst solubility thereby found to afford more 
%ee than other solvents. So far equal mixture of toluene and dioxane provided the 
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highest enantioselectivity (Table 11, entry 7) .Surprisingly in the case of 1,4-
dioxane:hexane (1:1) lowering the polarity for dioxane, resulted in lower 
enantioselectivity( Table 12, entry 14) 
Table 12. Optimization of C-2 alkylated asymmetric Tryptophan synthesis. 
N
N
OO
Br
O
N
O
N
H
N
O
O
PTC, Base
Solvent
N
O N
H2C
Br
H2C
27
67
68
 
Entry Base Solvent 
Temp. 
(oC) 
Time in 
hours % Conv. % ee 
1. 45% KOH THF rt 18 95 racemic 
2. 45% KOH Ether rt 18 7 30 
3. 45% KOH Toluene rt 18 80 50 
4. 45% KOH EtOAc rt 18 10 37 
5. 45% KOH CH2Cl2  18 90 racemic 
6. 45% KOH 1,4 Dioxane  18 95 42 
7. 45% KOH Acetonitrile  18 80 20 
8. Anhyd.KOH THF rt 18 85 racemic 
9. Anhyd.KOH DMSO rt 12 80 15 
10. Anhyd.KOH Toluene rt 12 85 50 
11. KOH (solid) Toluene 0 12 50 30 
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12. KOH (solid) 
Toluene: 
Methanol (5:1) 
rt 
12 85 45 
13. LiOH 
Toluene:MeOH 
(5:1) 
rt 
12 
No 
reaction  
14. KOH Dioxane:Hexane rt 12  25 
 
In the mean time, Huisman completed the synthesis of achiral tryprostatin B.  After 
asymmetric synthesis of tryptophan, deprotection of amino group proceeded 
smoothly under 1M HCl in THF at room temperature( Scheme 77) 
N
H
N
O
O
N
H
NH2
O
O
1 N HCl 
THF, rt
6968
 
Scheme 77. Deprotection of tryptophan amino group. 
In the next step Fmoc-proline coupling of compound 69 was also achieved in 66% 
yield (Scheme 78), but the last step of the synthesis i.e., ring closing was found to 
be a difficult reaction. The bulky tert-butile group of tryptophan ester made amide 
cyclization an unfavored choice in the diketopiperizine 46 formation. Refluxing 
compound 70 in xylene didn’t work as reported by professor cook’s group. Our 
attempts to tranesterfication reaction with methanol and ethanol to make it into 
methyl and ethyl ester were found to be unsuccessful. This is due to the stability 
of the compound rendered by t-butyl ester, primary and secondary alcohol couldn’t 
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replace t-butyl group. This problem was avoided by running the cyclization reaction 
under microwave condition for just 10 min . 
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90% yield
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Scheme 78. Total synthesis of Tryprostatin B from gramine. 
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5.3. Future work: 
Synthesis of Tryprostatin A is in progress, corresponding tryptophan analogs has 
already been made. Once we have tryprostatin B made, our group can focus on 
making tryprostatin A.  Several other tryprostatin analogs could be made by 
varying R1  for Ring A substitution variation, R2 N alkylation, R3 C 2-position 
functionalization, R4 Different amino acid condensation (Figure 18 and 19).  Some 
derivatives at all positions have been tested by Professor Cook’s group.   
N R3
HN
N
O
O
H
H
R1
R2
(CH2)n R
4
 
Figure 18 . Substitution at different position of tryprostatin. 
N N
H
HN
N
O
O
H
H
N
H
HN
N
O
O
H
H
H3CO
N
H
HN
N
O
O
H
H N
H
HN
N
O
O
H
H
N
H
HN
N
O
O
H
H
N
H
HN
N
O
O
H
H
F N
H
HN
N
O
O
H
H
Br
N
H
HN
N
O
O
H
H N
H
HN
N
O
O
H
H
OCH3
OCH3
H3CO
H3CO
Br
H3C
 
Figure 19. Potential targets for tryprostatin analogs by varying ring A substitution. 
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5.3.  General methods and Experimental 
General procedure: All procedures were performed under a dry nitrogen 
atmosphere using standard Schlenk techniques unless otherwise noted, all 
reaction vessels were flame dried under vacuum and filled with nitrogen prior to 
use.  Reagents were purchased from Aldrich Chemicals and used as is.  Flash 
chromatography was performed using EM Science F254 silica gel 60.  N-
(diphenylmethylene) glycine tert-butyl ester, sodium hydroxide, phase transfer 
catalysts and anhydrous sodium sulfate were purchased from Aldrich.  The 
chemical shifts (δ) are expressed in ppm relative to tetramethylsilane. CDCl3 was 
used as the solvent.  Previously 1H NMR or GC identified reported compounds.  All 
new compounds were additionally characterized by 1H NMR, 13C NMR and GCMS. 
 Instrumentation: 
All 1H (300 MHz), and 13C (75.5 MHz) NMRs were performed with a Burker 300 
and samples dissolve ni CDCl3 unless otherwise noted.  Enantioselectivity was 
obtained via chiral HPLC using a Waters setup including an Inline Degasser AF, 
2998 Photodiode Array Detector, 1525 Binary HPLC Pump equipped with Breeze 
Software.  This was equipped with a Chiralcel OD (column no. OD00CE-FF071) 
column using hexane and isopropanol at 254nm and a broad range channel from 
200-600nm column temperature was room temperature flow rate was 1 mL/min 
unless otherwise stated.   HPLC grade solvents were used in all HPLC analysis.   
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General Procedure for the Synthesis of tert-butyl 2-
(diphenylmethyleneamino)-3-(1H-indol-3-yl)propanoate: 
For each experiment, 1.0-5.0 mmol of the substituted gramine dissolved in 5-25 
mL of freshly distilled dichloromethane under nitrogen. 1 equivalent of 4-
(trifluoromethoxy) benzyl bromide was added and allowed to react. A tan slurry 
immediately resulted. After 1 hour N (diphenylmethylene) glycine-tertbutyl ester, 1 
equivalent, O-allyl-N-(9-anthracenylmethyl)-cinchoninium bromide, 0.2 
equivalents, were charged to solution through open air at ambient temperature. 
The reaction mixture was then cooled to –30 °C. While stirring, solid KOH 20 
equivalents were charged to the reaction mixture along with deionized water 6 
equivalents. Stirring was maintained at –30 °C for 8 hours. The crude reaction 
mixture was directly charged onto silica gel and subjected to flash 
chromatography, using 10% ethyl acetate pentane mixture. Product was then 
confirmed by NMR spectroscopy by comparing spectra to known 1H NMR. 1H, 13C 
NMR, High Resolution Mass spectra and elemental analysis were used to 
characterize the new compounds. %ee determined by HPLC. All HPLC 
chromatograms were run using Chiralcel OD column number OD00CE-FFO71.  
tert-butyl 2-(diphenylmethyleneamino)-3-(1H-indol-3-yl)propanoate(Scheme 
65; Compound 24); 
The general procedure was followed (10-20 hrs). Gramine (300 mg, 1.7 mmol), 
CH2Cl2 (10 mL) 4-(trifluoromethoxy) benzyl bromide (0.43 g, 1.7 mmol), N-
(diphenylmethylene) glycine-tert-butyl ester (0.502 g, 1.7 mmol), O-allyl-N-(9-
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anthracenylmethyl)-cinchoninium bromide (0.209 g, 0.3 mmol), solid KOH (2.0 g, 
36 mmol) and de-ionized water (0.2 mL, 11.1 mmol) were used to obtain the 
product (578 mg, 80% yield) as yellow oil. 1H NMR 
spectra matched.65 
1H 1.5 (s, 9H); 3.2-3.35(m, 2H); 4.1-4.4 (m, 1H; 6.6-7.7 
(m, 15H); 8.0(br. S 1H) 
 
tert-Butyl 2-(Diphenylmethyleneamino)-3-(5-methoxy- 1H-indol-3-
yl)propanoate (Scheme 65; Compound 39): 
 1H NMR (300 MHz, CDCl3): δ = 8.19 (s, 1 H), 7.59 
(d, J = 7.9 Hz, 2 H), 7.27–7.43 (m, 4 H), 7.15–7.20 
(m, 3 H), 6.93 (s, 1 H), 6.78–6.83 (m, 2 H), 6.61 (d, 
J = 7.5 Hz, 2 H), 4.33 (dd, J = 8.7, 4.5 Hz, 1 H), 3.69 
(s, 3 H), 3.44 (dd, J = 14.1, 4.5 Hz, 1 H), 3.30 (dd, J = 14.1, 8.7 Hz, 1 H), 1.47 (s, 
9 H). 13C NMR (75 MHz, CDCl3): δ = 171.4, 170.1, 153.6, 139.6, 136.1, 131.1, 
130.0, 128.7, 128.3, 128.0, 127.9, 127.6, 124.0, 112.0, 111.8, 111.6, 100.5, 81.0, 
66.6, 55.7, 45.2, 29.3, 28.0. HRMS: m/z [M + H]+ calcd. for C29H30N2O3: 455.2335; 
found: 455.2353. 
 
tert-Butyl 2-(Diphenylmethyleneamino)-3-(6-methoxy-1H-indol-3-
yl)propanoate (Scheme 65; Compound 40): 
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 1H NMR (300 MHz, CDCl3): δ = 8.39 (s, 1 H), 7.63–
7.71 (d, J = 7.9 Hz, 2 H), 7.28–7.41 (m, 4 H), 7.18–
7.25 (m, 3 H), 6.84 (d, J = 2.4 Hz, 2 H), 6.67–6.80 
(m, 3 H), 4.36 (dd, J = 8.4, 4.8 Hz, 1 H), 3.82 (s 3 
H), 3.46 (dd, J = 14.1, 4.8 Hz, 1 H), 3.27 (dd, J = 14.1, 8.4 Hz, 1 H), 1.48 (s, 9 H). 
13C NMR (75 MHz, CDCl3): δ = 171.5, 170.2, 156.1, 139.6, 136.7, 136.2, 130.1, 
128.7, 128.1, 128.0, 127.9, 127.6, 122.0, 119.4, 111.7, 109.0, 94.4, 80.9, 66.8, 
55.6, 45.2, 29.4, 28.0. HRMS: m/z [M + H]+ calcd. for C29H30N2O3: 455.2335; 
found: 455.2349. 
 
tert-Butyl 3-(5-Bromo-1H-indol-3-yl)-2-(diphenylmethyleneamino) 
propanoate (Scheme 65; Compound 41): 
 1H NMR (300 MHz, CDCl3): δ = 8.09 (s, 1 H), 7.80–
7.90 (d,J = 7.9 Hz, 2 H), 7.60–7.70 (m, 3 H), 7.18–
7.41 (m, 9 H), 7.00 (s, 1 H), 6.65 (d, J = 3.32 Hz, 2 
H), 4.24 (dd, J = 8.4, 4.8 Hz, 1 H), 3.36 (dd, J = 14.1, 
4.8 Hz, 1 H), 3.21 (dd, J = 14.1, 8.4 Hz, 1 H), 1.45 (s, 9 H). 13C NMR (75 MHz, 
CDCl3): δ = 171.0, 170.2, 135.9, 134.5, 130.0, 129.9, 128.6, 128.3, 128.2, 128.0, 
127.9, 127.4, 124.4, 124.3, 121.6, 112.4, 112.2, 112.0, 81.0, 66.4, 28.9, 28.0. 
HRMS: m/z [M +H]+ calcd. for C28H27BrN2O2: 503.1334; found: 503.1297. 
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Synthetic procedure for N Boc Gramine: 
 
Scheme 79. Preparation of Boc-protected gramine. 
This reaction was modeled after a very similar reaction discussed in Tetrahedron 
55 (1999) 10989-11000, compound 8 to 9.  A solution of gramine (3.7 g 0.021 mol 
1 eq.) in THF (90 mL) was made.  This solution was put into an addition funnel on 
a 250 mL three necked reaction vessel in an ice water cooling bath and added 
dropwise to a stirred solution of di-t-butyl dicarbonate (5.50 g 0.025 mol 1.2 eq.), 
4-(dimethylamino)pyridine (257 mg, 0.0021 mol 0.1 eq.), triethylamine (3.5 mL, 
0.0025 mol, 0.12 eq.) in THF (50 mL).  After stirring for 1.5 hours at room 
temperature, water was added to the reaction mixture.  The organic layer was 
separated and the aqueous layer was extracted twice with ether.  The combined 
extract was washed three times with water and then with brine solution and dried 
over sodium sulfate, and evaporated.  The residue was chromatographed over 
silica gel using hexane:ethyl acetate (5:1) as an eluent to give 5.18 g of Boc 
Gramine product in 90.0% yield.   
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Synthetic procedure for N+ diisoprenyl bromide salt of gramine 
N
N
OO
N
N
OO
Br
n-BuLi
Br
-70°Cto rt, THF
C16H22N2O2
Mol. Wt.: 274.36
C26H39BrN2O2
Mol. Wt.: 491.5  
Scheme 80. Synthesis of gramine quaternary salt 68. 
5.0 g (0.0182 mol, 1 eq.) Boc Gramine was weighed out in a beaker.  500 mL 
three-neck with thermometer adapter round bottom flask was oven dried for 3 
hours with stir bar inside.  It was removed from the oven and clamped.  On one 
neck rubber septum was inserted, in the other nitrogen outlet was inserted, at this 
point the boc gramine was charged to the flask via a powder funnel, and in the last 
neck nitrogen inlet was inserted,  as quickly as possible.  To the reaction vessel 
blue distilled THF (245) mL was charged via syringe.   The reaction mixture was 
allowed to stir for 1 hour to insure that all of the starting material was dissolved in 
the solution.  At this point solution is orange/peach in color.  Reaction vessel was 
cooled in a dry ice/acetone bath until reaction was -70 °C.  At this time n-butyl 
lithium (14.58 mL 2.5 M 0.03644 mol 2.0 eq.) was added dropwise to the reaction 
vessel via a syringe over 1 hour, maintaining a temperature range between -65 
and -70 °C.  At this point the reaction is bright red/orange.  After addition of n-butyl 
lithium reaction was let stir undisturbed for 1 hour and 30 minutes at -70 °C.  
Isoprenyl bromide (9.4 mL 0.08199 mol 4.5 eq.) was added to the reaction 
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dropwise.  After addition of isoprenyl bromide the color of the reaction mixture is 
orange.  At this point the reaction was left to warm overnight.  When returning the 
next day color of the reaction mixture was clear orange.  Deionized water (5 mL) 
was added to the reaction vessel, no reaction indicated that the n-butyl lithium was 
quenched.  At this point the solvent was removed using the roto vap.  After organic 
solvent was removed the water and residue was poured into a separatory funnel 
and extracted with dichloromethane three times (50 mL).   Organic layer was dried 
over sodium sulfate.  Solvent was removed via roto vap and high vac with cold 
finger.  Residue was purified using flash chromatography (10 x 6 cm silica gel) 
eluent was 5% methanol: 95% dichloromethane to provide a light brown solid 6.14 
g in 69% yield. See TLC plate developed in 9:1 Dichloromethane:Methanol 
observed with short range UV lamp and stained with ninhydrin stain and heated 
on a hot plate until colored.  Spot with Rf of 0.5 is product and has a purple/violet 
color when the TLC plate is developed in the ninhydrin stain. 
N
N
OO
Br
O
N
O
N
H
N
O
O
PTC
45% KOH
Acetonitrile
C26H39BrN2O2
Mol. Wt.: 491.5
C19H21NO2
Mol. Wt.: 295.38
C33H36N2O2
Mol. Wt.: 492.65
N
O N
H2C
Br
H2C
C37H37BrN2O
Mol. Wt.: 605.61
 
Scheme 81. Synthesis of protected C-2 alkylated tryptophan. 
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N-isoprenyl-2-isoprenylbocgramine (2 g, 0.004069 mol, 1 eq.) N-
(diphenylmethylene) glycine tert-butyl ester (0.004069 mol, 1.202 g) and O-allyl-
N-(9-anthracenylmethyl) cinchonidinium bromide (0.8192 mmol, 0.4961 g 0.2 eq) 
dissolved in acetonitrile (30 mL) in a 250 mL round bottom flask with a stir bar.  
Reaction mixture was allowed to stir for 30 minutes.  At this point the reaction 
mixture is a dark brown color with a light yellow precipitate that appears to be the 
phase transfer catalyst.  At this point 20 mL 45% KOH solution was added to the 
reaction mixture and allowed to stir, the aqueous layer was on the bottom and was 
clear and light yellow and the organic layer was dark brown and on the top.  
Reaction was allowed to stir for 20 hours; at this point the reaction has a dark layer 
on top and a clear orange layer on bottom.   A small sample was pulled from the 
reaction vessel, dissolved in CDCl3 and taken to the 300 NMR where I looked for 
the singlet at 4.1 representing the CH2 peak from the glycinate, disappearance of 
this peak indicates that the reaction has gone to completion.  From previous 
attempts at this experiment if the singlet at 4.1 remains add more KOH and let the 
reaction continue.  After confirmation that the reaction has gone to completion, 
solvent was removed from the reaction by rotovap leaving water and an orange 
residue on top of the water.  Dichloromethane (3x 50 mL) was added to the reaction 
vessel this solution was put into a separatory funnel with 50 mL deionized water 
diluting the water layer enough that the density becomes less than the 
dichloromethane.  Organic layer was collected and dried over sodium sulfate.  
Solvent was removed weight of this portion is 2.9158 g.  Thin layer 
chromatography (TLC) was used to identify a solvent system for column 
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chromatography, TLC indicated that mobile phase for the column should be 9:1 
Hexane:Ethyl Acetate.  Column used was 9 cm tall by 6 cm wide, isolating 1.21 g 
of product in 60.5 % yield.   
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a) Copies of 1H, 13C, HRMS, and HPLC Spectral Data   
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Portrait 5, Compound 7c 
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Portrait 7, Compound 7d 
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Portrait 9, Compound 7e 
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Portrait 11, HRMS 
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Portrait 12, Compound 7f 
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Portrait 14, Compound 7g 
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Portrait 15 
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Portrait 16, HRMS 
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Portrait 17, Table 3, Compound 7h 
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Portrait 19, Compound 8a 
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Portrait 21, HPLC Data(Racemic) 
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Portrait 22, HPLC Data(chiral)   
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Portrait 23, Compound 8b 
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Portrait 24 
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Portrait 25, HPLC Data( racemic)  
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Portrait 26, HPLC Data( chiral) 
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Portrait 27, Compound 8c 
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Portrait 29, HPLC Data(racemic)  
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Portrait 30, HPLC Data (chiral)     
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Portrait 31, Compound 8d 
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Portrait 33, HPLC Data (racemic)  
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Portrait 34, HPLC Data (chiral)  
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Portrait 35, Compound 8e 
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Portrait 37, HPLC Data( racemic) 
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Portrait 38, HPLC Data( chiral)     
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Portrait 39, Compound 8f 
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Portrait 40 
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Portrait 41, HPLC Data (racemic)    
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Portrait 42, HPLC Data (chiral)    
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Portrait 43, Compound 8g 
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Portrait 45, HRMS, Compound 8g 
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Portrait 46, HPLC Data(racemic)  
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Portrait 47, HPLC Data (chiral)  
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Portrait 48, Compound 8h 
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Portrait 50, HPLC Data (racemic)    
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Portrait 51, HPLC Data (chiral)     
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Portrait 52, Compound 14 
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Portrait 53 
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Portrait 53, HRMS, Compound 14 
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Portrait 54, Compound 15 
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Portrait 56, HRMS, Compound 15 
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Portrait 57, Compound 16 
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Portrait 59, HRMS, Compound 16 
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APPENDIX B: PART II, Analytical Data         Portrait 60 
          tert-butyl 2-(diphenylmethyleneamino)-3-(1H-indol-3-yl)propanoate(Scheme 65; Compound 24); 
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Portrait 62, HPLC traces for racemic tryptophan: 
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Portrait 63, HPLC traces for Chiral Tryptophan: 
 
 
 
 
 
 
P
e
a
k
1
0
 
-
 
1
5
.
8
6
9
P
e
a
k
1
1
 
-
 
1
7
.
5
1
5
A
U
-0.010
0.000
0.010
0.020
0.030
0.040
0.050
0.060
0.070
0.080
0.090
0.100
Minutes
14.80 15.00 15.20 15.40 15.60 15.80 16.00 16.20 16.40 16.60 16.80 17.00 17.20 17.40 17.60 17.80 18.00 18.20 18.40 18.60
 Name Retention 
Time 
Area % 
Area 
Height Int 
Type 
Amou
nt 
Units Peak 
Type 
Peak 
Codes 
1
0 
Peak1
0 
15.869 3585
419 
7.33 77144 VV   Found Q20  
1
1 
Peak1
1 
17.515 1076
641 
2.20 19864 VB   Found Q20  
 
 
 
 
1
9
9
 
Portrait 64 
tert-Butyl 2-(Diphenylmethyleneamino)-3-(5-methoxy- 1H-indol-3-yl)propanoate (Scheme 65; Compound 39): 
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Portrait 66 
tert-Butyl 2-(Diphenylmethyleneamino)-3-(6-methoxy-1H-indol-3-yl)propanoate (Scheme 65; Compound 40): 
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Portrait 67 
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Portrait 68 
tert-Butyl 3-(5-Bromo-1H-indol-3-yl)-2-(diphenylmethyleneamino) propanoate (Schem 65; Compound 41): 
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Portrait 70 
tert-butyl2-((diphenylmethylene)amino)-3-(2-(3-methylbut-2-en-1-yl)-1H-indol-3-yl)propanoate (Compound 68): 
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Portrait 72, HPLC Traces for racemic compound 68: 
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Portrait 73, HPLC Traces for chiral compound 68: 
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